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Plasma medicine, specifically non-thermal plasma (NT-plasma) technology, has 
clinical potential in medicine and biology, which has yet to be realized. Current concepts 
being tested range from wound healing, cancer suppression and dental applications. To 
date clinical trials testing NT-plasma have mainly focused on its bacteriostatic and 
bacteriocidal properties in patients possessing chronic and acute wounds, or diverse skin 
and itching diseases. Further development of NT-plasma as a clinical tool depends on 
gaining a better understanding of the mechanisms underlying NT-plasma interactions with 
living organisms. Several strategies have been employed including; characterizing NT-
plasmas, determining cellular response to specific NT-plasmas and identification of NT-
plasma modifications to the environment surrounding cells and tissues. The successful 
accomplishment of these goals and to prove plasma medicine has true clinical potential 
requires a multiple disciplinary approach where physicists, chemists, biologists, and 
electrical, mechanical and biomedical engineers work together with clinicians to meet the 
needs of the medical community. 
The best-characterized mechanism underlying NT-plasma activity on both 
eukaryotic and prokaryotic cells is the generation of ROS and RNS at the cell/environment 
interface which elicits an immediate intracellular oxidative response. This thesis tests the 
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hypothesis that NT-plasma promotes redox dependent changes to enhance developmental 
and cellular signaling. Initially, NT-plasma parameters including electrode size, plasma 
dose, filament formation and energy density were compared to determine both cellular 
response and treatment effectiveness. Once established, we were able to establish the 
mechanisms by which NT-plasma generated intracellular ROS and extra- and intracellular 
calcium flux promote murine limb autopod development and mesenchymal cell 
differentiation.  
Results of this study indicate that if NT-plasma is applied under the appropriate 
conditions it induces chondrocyte differentiation, osteoblast differentiation and promotes 
mouse limb autopod development. Effective NT-plasma dose was governed by both the 
biological model to which it was applied and to electrode geometry and size. Specifically, 
energy density was not an effective method for predicting cellular response nor to 
determine the resulting filament pattern created by the electrode. The cellular response at 
frequencies above 50 Hz filamentation pattern were instead strongly dependent on 
electrode size. Having established these conditions, we determined the biological responses 
to NT-plasma were dependent on increases in intracellular ROS production and the 
resulting activation of oxidative-stress responsive proteins and gene expression. 
Furthermore, both cellular differentiation and the enhancement of limb autopod elongation 
by NT-plasma were dependent on increases in intracellular calcium, through the activation 
of voltage gated calcium channels on the plasma membrane. In conclusion, this thesis 
identifies the potential of plasma medicine technology to induce and recapitulate normal 
cellular signaling and its potential in regenerative medical applications for skeletal tissue 
engineering, and if directly applied to improve healing after skeletal injury. 
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 Preface  
 
The success of plasma medicine technology depends on the collaboration between 
scientists from multiple fields, including physicists, biologists, engineers and clinicians, to 
meet the challenges that require attention specific to their expertise. Thus, the potential 
application of NT-plasma to living organisms requires a multidimensional collaboration. 
Furthermore, this requires an understanding of NT- plasma, controlling its properties, 
exploring the interactions with the extracellular environment surrounding cells and the 
ability to selectively alter or promote biological function. All of which are equally 
important requirements for translating NT-plasma into a clinically relevant application.   
 
 
Figure 1: Physicists, biologists, chemists, clinicians and engineers contribute to the success of plasma 
medicine. 
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The overlap between biology, physics and engineering in the plasma medicine field 
presents opportunities for all the participants to learn more about the other discipline. 
However, as an Engineer working in a biological lab, I have witnessed firsthand the 
challenges of communicating concepts with scientists from different disciplines. The lack 
of common language presents a formidable barrier to communal communication, 
understanding and development of cohesive project development. 
The hands on experience I received working in an orthopedics lab provided me 
unique insight into the potential of NT-plasma treatment of cells and tissues, which would 
not have been possible working in a strictly engineering environment. Differences in 
experimental techniques between liquid vs cell or tissue experiments were astronomical. 
As a result of learning these differences, I have gained a better understanding of both 
biological and plasma processes.  
In summary, the focus of this thesis was to gain a better understanding of the 
potential of NT-plasma to promote cell differentiation and tissue development and the 
mechanisms involved using a threefold approach: physical, chemical, and biological. 
First proof of the concept that NT-plasma can enhance tissue development was 
established. Then NT-plasma treatment efficiency was compared by altering physical and 
electrical plasma parameters. Next, the mechanism of how NT-plasma interacts with 
living tissue to initiate cell signaling and control cellular differentiation and tissue 
developmental was explored. Finally, using the insight gained exploring the first two aims 
we established that NT-plasma can be fine-tuned to promote the desired biological 
responses.  
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 It is my hope that this seminal work will provide the basis for further experiments 
to develop a deeper understanding of the physical properties of NT-plasma required to 
promote outcomes specific to additional biological applications.   
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 Background 
2.1. Plasma-the Fourth State of Matter 
The word “plasma” in the context of electric plasma, is attributed to Irving 
Langmuir, who claimed it reminded him of blood plasma due to its multi-component nature 
[1]. In fact, electric plasma is the fourth state of matter defined as an electrically neutral 
area where electrons and ions coexist. In the well-characterized solid - liquid - gas 
transitioning of the states of matter, which occur as temperature and molecular entropy 
increases; plasma follows gas (Figure 2).  
 
 
Figure 2: Plasma is a distinct state of mater. For most materials an increase in energy transforms the mater 
from solid to liquid to gas and then to plasma. Some exclusion apply. 
 
The transitioning of gas into plasma can be accomplished by different mechanisms. 
For example,  a gas can be super-heated to form plasma or when a high electric field (in 
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air - approximately 30 kV/cm [2]) is applied to the gas it will initiate the breakdown into 
ions and electrons which continue to accelerate in the electric field propagating the 
ionization.  
Plasmas have been divided into two categories: thermal and non-thermal (NT); 
which is also referred to as non-equilibrium plasma. In both plasma types, the mean 
electron temperature is on the order of 10,000K (1eV). However, in non-thermal plasma 
the electrons are not in thermodynamic equilibrium with the background gas, and the gas 
temperature is at least one order of magnitude lower than the electron temperature [2]. The 
high temperature electrons participate in excitation and dissociation reactions leading to 
the formation of metastable products, reactive species, radicals and cause radiation. In 
thermal plasma, gas and electron temperature have the same order of magnitude. A 
transition between thermal and non-thermal plasmas takes place at about 2500 K [2]; this 
is why the term non-thermal plasma (also sometimes called cold plasma) is misleading as 
non-thermal plasma can have a sustained gas temperature as high as 2000 K.  
There are several examples of plasma phenomenon occurring in nature. Lightning 
is an example of a thermal atmospheric pressure plasma and the Northern Lights (Aurora) 
is an example of a non-thermal atmospheric pressure plasma.  Both types of plasma can be 
constructed in the laboratory as well. 
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2.2. Plasma Medicine 
Plasma medicine can be defined as the study of non-thermal ionized gas plasmas 
for therapeutic use. Although the field of plasma medicine emerged only about 10 years 
ago, medicine has exploited high temperature plasmas, and the concentrated heat they 
generate, for the purpose of tissue removal, sterilization, and cauterization (cessation of 
bleeding) for several decades [3-7]. While high temperature plasmas are exploited for the 
fine control of high temperature (plasma knife), it is postulated that the therapeutic effects 
of non-thermal plasma is attributable to its production of reactive oxygen and nitrogen 
species, free ions, electromagnetic radiation and fields, and the radiation of UV, infrared 
and visible light [8] (Figure 3).  
 
 
Figure 3: Non-Thermal Plasma components: reactive oxygen and nitrogen species, positive and negative 
ions, electromagnetic fields, and different types of radiation. 
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To exploit this technology plasma medicine applications are divided into three 
major initiatives: modification of the bio-surface with plasma, biological decontamination 
and direct application for therapeutic effects [8]. To date, the most progress has been 
reported for biological decontamination, with multiple demonstrations of non-thermal 
plasma (NT-plasma) bactericidal effectiveness. These reports include: NT-plasma induced 
damage of the bacterial cell membrane [9], reduced survival and voided regions formed 
after NT-plasma irradiation of the surface without damage [10] [11, 12], reduction of cell 
viability, and prevention of reoccurrence of bacteria after biofilm treatment [13-15]. 
Medical treatments with NT-plasma include sterilization of chronic wounds to improve the 
healing rate [16] [17, 18] and dental applications of effective biofilm removal [19, 20]. 
Phase II clinical trials for NT-plasma treatment of wounds showed a significant reduction 
of bacteria cells in the area treated by NT-plasma as compared to control [17, 18]; with no 
side effects, including pain during or after NT-plasma application. Another study reported 
NT-plasma did not cause skin dryness or damage to the skin surface during the treatment 
[21]. Other studies in mice show that non-thermal plasma (NT-plasma) can speed blood 
coagulation [16] and result in accelerated healing compared to untreated wounds [22]. 
More recently, NT-plasma has been investigated for use in the treatment of cancer. Several 
studies report the killing effects of NT-plasma on cancer cells [23-25]. Specifically, studies 
on melanoma [26-29], ovarian [30], colorectal[31], liver [32], lung [33], breast [34], and 
brain [35] cancers, provide a glimpse into the potential of NT-plasma as an effective 
treatment option. A detailed overview of NT-plasma’s potential as a cancer treatment, 
compared to other available treatments is provided in a review by Hirst at el [36].  
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2.3.  Confounding conditions for plasma treatment in biomedical applications 
Several challenges exist in the design of NT-plasma devices for the biomedical 
applications described above. Theoretically, it should be possible to engineer the plasma 
source to selectively determine its action and control the plasma properties to produce 
specific plasma parameters. However, it remains a challenge to accurately characterize, 
model or provide measurement diagnostics of the NT-plasma produced. Additionally, 
when plasma ignition occurs in open-air atmospheres, at atmospheric pressures, it 
generates variable amounts and types of ions and species; thus creating additional 
challenges in maintaining a consistent plasma.  Additional variations in the discharge are 
created as dictated by the Paschen curve, which states the size of the discharge is reversibly 
proportional to the pressure, dictating small NT-plasma discharges will be produced [2]. 
These discharges are not uniform, they are constricted or filamentary due to the streamer-
breakdown process. They are also transient due to high collision rates and quenching.  
Adding to the complexity are the variations within the biological target, which are even 
more complex and induces non-linear couplings and feedback loops. Finally, if liquid 
solutions are present (such as media, blood or saline) interaction with the plasma will 
produce complex chemical reactions [37].   
While these complexities are numerous, over the years multiple laboratories have 
employed various plasma sources for formation and delivery of plasma in biomedicine. 
Some examples include: floating-electrode dielectric barrier discharge (FE-DBD) [10, 16, 
26], helium plasma jets [27, 38, 39], plasma needle[40], dielectric barrier discharge (DBD) 
[41], atmospheric-pressure plasma plume [42], atmospheric-pressure glow discharge torch 
[43], nanosecond plasma gun [44], micro-hollow cathode discharge air plasma jet [45] and 
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microwave plasma torch [46]. Although this list is far from complete, two major discharge 
categories, plasma jets and dielectric barrier discharges, are explored in the next sections. 
 
 Dielectric Barrier Discharge 
2.3.1.1 Principles of Operation of the Dielectric Barrier Discharge 
Dielectric Barrier Discharge (DBD) is created in atmospheric air or other gasses 
when high voltage of sinusoidal waveform or short duration pulse is applied between two 
electrodes separated by at least one dielectric barrier [47, 48]. A typical schematic of the 
discharge configuration is presented in Figure 4. Two main configurations of this discharge 
are Volume Barrier Discharge (VBD) and Surface Barrier Discharge (SBD). A volume 
barrier discharge (VBD) is configured so that one or both electrodes are isolated from the 
discharge gap. The VBD can be directly applied to the treated object that serves as a second 
electrode. In the SBD, the isolator is in contact with both electrodes and the plasma is 
formed near the electrodes on the isolator surface, while the VBD can be directly applied 
to the treated object, which serves as the second electrode. 
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Figure 4: Example of Dielectric Barrier Discharge Configuration (modified from [49]) 
 
 Dielectric barrier discharges exhibit pronounced filamentary characteristics, self-
organized regular-discharge patterns, or completely diffuse appearance, depending on a 
variety of gas properties, operating parameters and boundary conditions. The electrode 
configuration as presented in Figure 4 results in a large number of short-lived current 
filaments, as reported in many papers [50-56]. High collision rates at atmospheric pressure, 
results in a growing electron avalanche which can generate appreciable charge density at 
its tip after traveling a short distance (Figure 5 and Figure 6, [57]). The local electric field 
due to charge separation resulting from the difference in drift velocities of electrons and 
ions is superimposed on the applied field. At the streamer head, high-field region is created 
causing collisional ionization which leads to fast propagation of the ionization region and 
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the formation of a bright plasma channel. The streamer velocity is in the range 107-108 
cm/s, and the radius of the propagating streamer head and the resulting ionized channel is 
about 10-2 -10-1 cm. Numerical models showed that the reduced field E/n at the streamer 
head can reach 500 to 800 Td (1 Td corresponds to 10-17 Vcm2), a value that is several 
times higher than the reduced field at breakdown (about 100 to 200 Td) [49].  In 
atmospheric-pressure air, the thickness of the propagating ionizing region is only 0.02 cm 
[58, 59]. Seed electrons for the propagating streamer are likely to be created by ultraviolet 
photoionization of the gas ahead of it. 
  
 
Figure 5: Schematic representation of individual filament formation in DBD. Stage 1: Avalanche Initiation 
[57] 
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Figure 6: Schematic representation of individual filament formation in DBD. Stage 2: electrons reaching the 
second electrode (right) ; Positive ion cloud formation once the electrode spread out to the dielectric 
surface.[57] 
 
In some biomedical applications, the direct application of plasma is preferred. 
Dielectric Barrier Discharge (DBD) can be safely applied to cells and tissue as the 
temperature of the gas can stay near room temperature. Safe, direct application of the DBD 
plasma was first demonstrated by Fridman et al [10, 60] using his finger as the second 
electrode. When the second electrode is a tissue, it is termed the “floating electrode” DBD 
mode. The presence of the dielectric on the first electrode prevents build-up of current 
between this electrode and the floating electrode. For biological applications, the most 
common dielectric is quartz and its thickness is 0.5-1mm [16, 61-63], but both the thickness 
and material of the dielectric can be varied depending on the application [49]. However, 
due the high pressure and high collision rate, DBD will also produce filaments and 
streamers, which can cause tissue damage. The typical microdischarge has a lifetime 1-20 
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(100) ns [49] and the radius of the filaments is 50-100 microns. The total transported charge 
is 0.1-1nC and each microdischarge contributes 5K heating. The gas temperature is close 
to room temperature and the total dissipated energy is 5µJ [64, 65].  
Minimizing micro-discharge formation and improving discharge uniformity can be 
achieved by igniting a higher number of avalanches by pre-ionizing the gas. The second 
option is to avoid inhomogeneous electric fields by making sharper voltage transitions [61, 
62]. Inhomogeneous electric fields promote avalanche growth in certain areas and suppress 
them in other areas. For very fast rising voltages, the electrode shape does not affect the 
location of the avalanches and streamers, resulting in a discharge independent from the 
topography. This property is important for direct application to tissue since the floating 
electrode (tissue surface) is not necessarily smooth or uniform. 
Plasma characterization of species generated show the surface treated by DBD is 
exposed to active short and long lived neutral atoms and molecules, including ozone (O3), 
NO, OH radicals, and singlet oxygen (O2 1Δg), and a significant flux of charged particles, 
including both electrons, and positive and negative ions like super oxide radicals. Non-
thermal plasma density, temperature, and composition can be changed to alter these plasma 
products to some extent. 
 
2.3.1.2 Wave fronts used to generate Dielectric Barrier Discharge Plasma 
DBD is usually ignited using either sinusoidal or pulsed waveforms. Sinusoidal 
waveforms results in stronger filaments with a higher electric field in the head of the 
streamer. Pulsed wave fronts are usually divided into microsecond or nanosecond, based 
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on the rise time of the applied voltage front. Nanosecond pulsed plasma is considered more 
uniform, as microsecond pulsed plasma has higher electric fields and is more filamentary 
in nature compared to nanosecond pulsed plasma. The chemical compositions also differ 
between the two, due to the differences in temperature within the discharge [66, 67]. 
Additionally, pulsed plasmas differ in the predominant species produced, as microsecond 
produces more OH radicals while nanosecond has higher singlet oxygen [68]. Applications 
of nanosecond pulsed plasma in biomedical context are relatively new and mostly applied 
for their bactericidal effects [69-71]. Microsecond plasma, which has been in use longer, 
has been shown to: kill microbes on wounds, burns, within intestines and on teeth, enhance 
wound healing, coagulate blood without damage of surrounding tissue, and effectively treat 
some malignancies [16, 20, 72, 73].   
  
2.3.1.3 DBD modes of operation: Direct, Indirect and Separable  
DBD can be applied to cell and tissues in direct and indirect modes [74] as well as 
in a separated mode [75] (Figure 7) to elicit a wider range of electrical and physical 
parameters.  In the direct mode, there is a direct contact between the ionized gas and the 
treated sample. In this mode of operation NT-plasma consists of positive and negative ions, 
short and long-lived reactive species (e.g. singlet oxygen, super oxide, ozone, peroxinitrite, 
etc.), electric fields and wide energy range photons [74]. In the indirect mode, ions are 
scavenged before they reach the sample and mostly long-lived reactive species reach the 
sample surface. Separated mode treatment occurs by treatment of the liquid alone followed 
by the application of the treated liquid to a sample [76, 77]. 
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Figure 7: Different operation modes of Dielectric Barrier Discharge: Direct, Indirect and Separated.  
 
 Plasma Jet  
Plasma generated as a jet (or plume) is produced by generation of plasma between 
two electrodes inside the nozzle followed by gas flow through the plasma creating the flow 
of plasma to the object to be treated. Many different jet configurations have been developed 
[38, 39, 45, 78-83]. Differences between these jets include differences in the frequency and 
magnitude of the applied voltage, the composition of gas where plasma is ignited and gas 
flow rate (several liters per minute). Jets can be categorized as either “remote” or “active”. 
Remote plasma jets are potential free defined by the recombining and relaxing of species 
generated inside the nozzle. Whereas, active plasma jets contain high-energy free electrons 
and the treated surface is considered as a second electrode.  
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Commonly configuration of the plasma jet is based on DBD where the NT-plasma 
is generated as DBD followed by flow of the carrier gas (e.g., helium or argon with a small 
amount (0.5%) of oxygen) which transports the plasma plume to the treated surface. When 
helium gas is used it creates a flexible parameter space for stable homogenous operation at 
cold gas temperatures [36]. In this configuration, the dynamic high electric field is parallel 
to the direction of propagation resulting is a self-propagating plasma plume. This 
configuration corresponds to the active jet, which contains charged particles and reactive 
oxygen and nitrogen species, electric fields and UV radiation. 
A less used type of jet is based on using a cross-field plasma source, which operates 
in the radiofrequency range. In this configuration, gas excitation is performed using a 
13.56MHz power source and plasma is generated in through parallel plane electrodes. This 
creates an applied electric field that is perpendicular to the carrier gas flow as it passes 
through the plasma core volume. This is a passive plasma jet dominated by energy carrying 
reactive oxygen and nitrogen species. This plasma source has been well characterized both 
experimentally and through modeling [84-88]. 
Plasma jets can be used for a wide range of biological applications including dental 
applications, cancer treatment and treatment of cells and tissues [19, 20, 81, 89-92]. A 
review by K.D. Weltmann at el , detailed macroscopic parameters of the plasma jets and 
how to eliminate potential risks for use in medical therapies [80]. He reported that jet 
temperatures could range between 46-63◦ C, with no detectable ultra violet (UV)-C 
emission in the 200 to 280 nm range, but with a considerable amount of vacuum UV (VUV) 
radiation.  In addition to VUV and heat radiation, the plasma jet generates a mixture of 
ROS and RNS, charged species and other toxic gases.  
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2.4. NT-Plasma Interaction with Cell  
In this section, the contributing plasma components interacting with cells will be 
discussed and the next section will describe potential cellular responses to NT-plasma. 
Before non-thermal plasma can be used for therapeutic application, the mechanisms of 
plasma interaction with multicellular organisms needs to be determined. Unfortunately, 
this is not a simple task due to the non-linear coupling and feedback mechanisms of the 
biological targets, and the complex nature of plasma and plasma chemistry. Plasma 
chemistry in the medium surrounding the biological target is beyond the scope of this 
dissertation. 
As was mentioned in regards to the DBD, NT-plasma can be applied in direct and 
indirect modes. In the direct mode short-lived species, which are the most reactive, come 
into contact with the treated substrate. In this regime, optimal energy transfer from plasma 
to target takes place, where the flux of species generated in the plasma have maximal 
interaction with the target. In this case, a physical current flows directly into the target. The 
surface is bombarded with positive energetic ions as the plasma sheath is formed near the 
treated object. Direct treatment is considered the most effective for NT-plasma 
decontamination and sterilization of biological surfaces. However, cell necrosis and 
devitalization is observed under these conditions. 
The indirect treatment is often referred to as an afterglow of the discharge. In this 
regime, no current is transferred to the target and most of the short-lived particles and 
charges do not reach it. Which long-lived species are generated by the plasma reaction is 
dependent on the gas mixture present when the plasma is ignited. In air, the dominant long-
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lived species is nitric oxide (NO) or ozone. Until recently, the indirect method was 
preferable for in vivo medical applications, as it was considered safer than direct treatment.  
Another possibility is the plasma treatment of the medium before adding it to cells. 
Studies have shown that plasma treatment chemically modifies the liquids in both direct 
and indirect modes [10, 74, 93]. Depending on the type of plasma (direct/indirect) and the 
composition of the liquid, plasma treatment induces changes in acidity [94, 95], through 
the production of reactive species including; hydroxyl radical, hydrogen peroxide, nitric 
and nitrous acid and others. The lifetime of the species in the liquid is also dependent on 
the liquid composition and acidity [95-99]. Studies have shown that plasma treatment 
sterilizes liquids, induces DNA damage and apoptosis of cancer cells [100-103]. Several 
methods have been used to decouple the NT-plasma components to their respective effects 
on cells and tissues. This task is difficult to achieve as during the NT-plasma treatment 
elements are in constant flux. In the broad sense, the elements produced by plasma 
treatment that are most likely to affect the cells and tissues are: heat, shear stress, reactive 
oxygen and nitrogen species, UV radiation and charged species. Plasma dose is often 
reported in the units of energy per unit of area or energy per volume of cells.  
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2.5. Mechanisms of Cellular Response to NT-Plasma treatment 
 
 
Figure 8: Examples of non-thermal plasma interactions with cells, including generation of intracellular 
reactive oxygen and nitrogen species, stimulation of bioelectric response (pH change, ion flux, etc), induction 
of cell permeabilization and even initiation of reparable or permanent DNA damage. 
 
 Changes to the Intracellular Reactive Oxygen and Nitrogen Species 
Concentration Following NT-Plasma Treatment 
A group of molecules that are generated through the partial reduction of molecular 
oxygen is called reactive oxygen species (ROS). Examples include superoxide anion  
(O2-), hydrogen peroxide (H2O2), and hydroxyl radical (OH.). These species are formed 
through sequential reduction of ground state molecular oxygen [104], and they have a 
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relatively short half-life, which distinguishes them from other oxygen-containing 
molecules. ROS production is directly proportional to cellular activity and the production 
of ATP by mitochondria. Proliferation, differentiation, migration, and growth are processes 
with high energetic use of ATP and subsequently require increased mitochondrial activity. 
Therefore, strict control of the ROS levels resulting from this activity is fundamental for 
proper development. 
Intracellular reactive oxygen and nitrogen species (iRONS) play a crucial role in 
physiological cellular functions and pathophysiological processes, including the activation 
of enzymatic cascades and transcription factors [105]. For example, superoxide anion  
(O2·–) and hydrogen peroxide (H2O2) can oxidize proteins, lipids and polynucleotides [106, 
107]. Changes to the cellular redoxy status by iRONS regulates both positive and negative 
cellular functions, including cellular migration, proliferation, differentiation, induction of 
apoptosis and necrosis [108-110]. Excessive iRONS signals are linked to variety of 
diseases (i.e. malignant diseases, neurodegenerative diseases, diabetes mellitus, 
ischemia/reperfusion injury [105]. To protect against the damaging potential of iRONS, 
cells developed an antioxidant defense system, which includes enzymatic and non-
enzymatic oxidant defense mechanisms. The intracellular redox state of the cell is the 
dynamic balance between iRONS production and the antioxidant capacity of the cell. The 
iRONS are generated in multiple intracellular sites. The two main sources of the iRONS in 
most cell types are mitochondrial electron transport production of ATP and membrane  
associated NADPH-oxidases. NADPH-oxidases are multienzyme complexes that produce  
O2·- in response to numerous receptor-mediated growth factor and cytokine signaling 
cascades. Another source of the iRONS is xanthine oxidase, although its cellular 
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distribution is more limited. The main iRONS produced by mitochondria and NADPH-
oxidase is O2·-, which is reduced to H2O2 either by spontaneous dismutation or catalyzed 
by superoxide dismutase (SOD). 
iRONS are known to directly activate multiple proteins involved in signaling 
pathways that regulate cell function. Specifically, iRONS-responsive MAP kinases are 
known to control a wide range of cellular processes including: cellular differentiation, cell 
cycle control, cytokine and growth factor signaling, survival, hypertrophy and/or apoptosis 
[111-114]. Map5kinase Apoptosis signal-regulating kinase 1 (ASK1), is particularly 
sensitive to ROS as its activity is tightly regulated by four iRONS sensitive proteins 
thioredoxin, glutaredoxin, Akt and 14-3-3 [114-118]. iRONS activated ASK1 
phosphorylates and activates both p38 and jnk kinases, which play key roles in cellular 
differentiation [119, 120] as well as the regulation of apoptosis [121]. Furthermore, 
activation of ASK1, p38 and/or jnk promotes the differentiation of several cell lineages 
including chondrocytes [122-124], osteoblasts, neuronal [125], myoblasts [126] and 
keratinocytes [111, 120, 124].  
It has been established that NT-plasma causes an increase in iRONS [25, 127, 128], 
which are important biochemical signaling molecules that play an essential role in both  
biology and medicine [129]. Other physical and chemical stimuli besides plasma such as 
shear stress,[130, 131] [132, 133] photodynamic therapy, [134, 135] and others [130-139] 
stimulate similar iRONS production and cellular responses. The common understanding is 
that the amount, species type and duration of oxidative stress are what regulate the different 
cellular functions [140, 141]. What remains unclear, is whether RONS produced by plasma 
in gas and liquid are the main source for the iRONS response or if other plasma components 
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such as electric field, shear stress and radiation are also responsible for iRONS production 
and to what extent each contributes.  
 Bioelectric Cellular Response (resting electric potential across plasma 
membranes, Voltage gated channels, pH) 
Supporting evidence that electric components of plasma also participate in the 
cellular effects induced by plasma treatment should not be neglected. The effects of 
electrical stimulation on and by cells and tissues have been reported in the scientific field 
of bioelectricity. Bioelectricity studies electromagnetic fields that are produced by living 
cells and tissues, which include cell behaviors affected by ionic signaling [142]. In addition 
to biochemical signaling, bioelectrical communication between cells occurs promarly 
through endogenous electric fields, ion flows and voltage gradients as a result of ion pumps 
and channels actions [142]. This communication is separate from redox signaling and 
signals produced by excitable muscle and nerves. The time scale is also much slower and 
occurs on the order of minutes to days [142]. 
The electric potentials gradients (Vmem) that exist across plasma-membranes are of 
particular interest, since NT-plasma penetration to cell and tissue is considered to be on the 
order of several microns [143, 144]. Examples include, differences in polarization between 
terminally differentiated versus more plastic cells [145], suggesting that changing the 
electric potential can effect Vmem and potentially induce cell differentiation. Moreover, 
endogenous electric field and ion currents have been reported to guide limb regeneration 
[146], tail development [147], cell migration and orientation of the embryo [148] in 
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amphibian, avian, and invertebrate model systems.  In addition Vmem can mediate 
proliferation control, differentiation state and neoplastic transformation [149, 150]. 
One hypothesis is that a multidimensional state space exists where each axis defines 
the value of a physiological parameter that can influence the differences in cell status ( 
such as undifferentiated, neoplastic etc.). Examples of physical parameters include Vmem, 
pH, levels of ions (such as calcium, sodium, chloride and potassium etc), nuclear membrane 
potential, cell surface charge (zeta potentials), etc. The hope is that through pharmacological 
and molecular-genetic means the transfer of properties along each axis can cause transition 
of cells from one state to another. It won’t be unreasonable to assume that NT-plasma can 
transition the cells from one state to another by altering the position of cells along those 
axises. 
 DNA damage  
Several studies have shown that cells undergo DNA damage following high doses 
of NT-plasma treatment [74, 81, 151]. NT-plasma treatment causes phosphorylation of γ-
H2AX histone indicating thymine cross-linking and DNA double strand breaks (DSBs) or 
DNA single strand breaks. The extent of the DNA damage response was proportional to 
NT-plasma treatment dose and DNA damage at lower NT-plasma doses was reparable 
[151]. After NT-plasma treatment, minimal effects on DNA were observed for doses below 
1 J/cm2, doses of 2 to 6 J/cm2 cause repairable DNA damage 24 hours post NT-plasma and 
doses above 7 J/cm2 lead to sufficient DNA damage that results in apoptosis [151]. 
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 Cell Permeabilization post NT-plasma treatment 
The literature suggests that NT-plasma -assisted cell transfection can take place due 
temporal cell permeabilization [152, 153]. Using an RF-pulsed NT-plasma jet it was 
demonstrated that molecules ranging from 3kDa up to 40kDa (radius of ~ 4.8nm) can enter 
pores on the cell-plasma-membrane. Although molecules up to 40kDa can enter the cell, 
their diffusion is limited compared to 10kDa particles (radius of 1.9nm). The authors 
reported that 70kDa particles with radius of ~6.5nm were unable to diffuse into the cells. 
Additionally, cell permeabilization was limited to areas where NT-plasma came in close 
contact with the cells. Since NT-plasma was used in the indirect mode during this study 
the authors suggested the mechanism behind cell permeabilization was lipid peroxidation 
following NT-plasma treatment [153] rather than charging [154]. 
 The Role of Calcium Divalent Cation as a Signaling Molecule. 
The calcium signaling system is very complex as calcium ions are extremely 
important in the induction of precise and rapid signaling responses in most organisms. Due 
to large gradients between the intracellular and extracellular concentration of free calcium 
(up to a 20,000 fold difference) most organisms must rely on the constant activity of 
calcium pumps to remove the calcium ions from the cytosol [155].  For comparison, 
intracellular to extracellular concentration gradient for potassium and sodium cations has 
no more than a 30-fold difference. Calcium dependent channels in the cell-plasma 
membrane include voltage-operated channels, transient receptor potential channels, second 
messenger operated channels and many others. G protein-coupled and tyrosine-kinase-
linked receptor families are two main ways calcium channels are controlled. 
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Flexibility in calcium signaling depends on calcium-sensing proteins, [156-158] 
calcium spatial patterns and variations in the frequency and rate changes of the calcium 
concentration which modulates the duration of the resulting calcium signal. Calcium-
sensing proteins respond to intracellular rises in calcium concentration, which determines 
the calcium ion binding kinetics in conjunction with the calcium-binding affinity of each 
protein.  Once binding takes place proteins undergo conformational changes, which initiate 
the signaling cascade. Specific signaling pathways will be activated for different levels of 
calcium concentration. In addition, spatio-temporal distribution and sensing of calcium ion 
concentration contributes to the signaling events. For example, a short and local calcium 
increase can take place following the short-term activation of some calcium channels. 
Positive feedback mechanisms also exist between the extracellular and intracellular 
sensors. As a result, channels might be inactivated after a certain time or if a certain level 
of calcium is achieved resulting in decreased calcium influx. In parallel, free calcium 
captured by calcium buffer proteins is pumped outside the cytosol. Regardless of the 
frequency of transient calcium level changes, the basal level of calcium is kept constant in 
most physiological processes. The time scale of calcium signaling is wide and ranges 
between milliseconds to hours. Amplification mechanisms also exist and involve calcium-
induced calcium release from endoplasmic reticulum to propagate fast intracellular calcium 
waves. Transmission of the fast propagating waves relies on the diffusion of calcium 
between the cytosols of adjacent cells through pores located at the gap junction [159]. 
Finally, cell excitation can lead to calcium entry through voltage-dependent calcium 
channel. This process is essential for electrical activity of the membrane and intracellular 
signaling.  
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 Cross talk between Calcium and ROS signaling 
Numerous studies have reported a coupled connection between calcium and iRONS 
signaling systems [160-162]. Cross-talk between the two signaling systems occurs across 
multiple subcellular compartments including the plasma-membrane, cytosol and 
mitochondria. The interplay between the two systems can be stimulatory or inhibitory 
depending on the iRONS species, time course, concentration and cell type. A detailed 
review by Y. Yan at el [163], describing the interplay, explains that calcium can play a dual 
role in maintaining balance of the redox state, by shifting it to either a reduced or oxidized 
states to maintain ROS homeostasis. Calcium was also found to increase ROS generation 
by enhancing metabolism and increasing ROS production by the mitochondria [164]. 
Additionally, calcium regulates multiple extra-mitochondrial iRONS generating enzymes 
in both physiological and pathological processes. For example, the activity of neutrophil 
oxidases, including NADPH-oxidase, is calcium dependent [165] and calcium can directly 
activate antioxidant enzymes [166, 167].  
iRONS on the other hand can also regulate calcium signaling. For example, H2O2 
opens and inhibits calcium voltage gated channels (such as P.Q, L-type) [168-170] and 
controls intracellular calcium release from the endo/sarcoplasmic reticulum [171-175]. 
iRONS regulation also activates or inhibits calcium pumps and the calcium/sodium 
exchanger [176-178]. The effect of both calcium on the redox state and ROS modulation 
of calcium is both ROS species-dependent and tissue-specific [166, 167, 179]. 
Studies have shown that iRONS can also induce dynamic changes in calcium in a 
variety of cell types [180-185].  This is particularly interesting in the case of NT-plasma, 
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since it was demonstrated that NT-plasma generates ROS in both gas and liquid phase 
[127]. Another reason to investigate intracellular calcium levels post NT-plasma treatment 
is based on studies reporting dynamic calcium changes following pulsed electric field [186, 
187], which is also produced during NT-plasma treatment. I believe that is correct and 
brings NT-plasma into context. 
 
 Calcium and ROS signaling in developmental and differentiation 
Numerous studies have demonstrated that calcium signaling is necessary for tissue 
elongation, cell reorganization and folding [165, 188-195]. In early stages of embryonic 
development, the intracellular calcium levels change, in conjunction with developmental 
steps [165, 188-195]. If intracellular calcium signaling is inhibited, the coordinated 
developmental chamges in all studied model organisms are eliminated [165, 167, 191, 193, 
196]. The use of calcium chelators is one method to inhibit intracellular calcium signaling. 
These chelators bind free calcium ions and prevent their participation in other reactions. 
The use of drugs such as thapsigargin is another method to perturb calcium signaling. 
Thapsigargin removes all calcium from intracellular stores and inhibit the ability of the cell 
to increase intracellular calcium by this mechanism.  
Skeletal component cells including osteoblasts, chondrocytes, adipocytes, 
myoblasts, tendon cells, and fibroblasts, are derived from mesenchymal stem cells. The 
lineages are determined by different transcription factors. The transcription factors, Runx2, 
osterix, and β-catenin, regulate osteoblast differentiation, Sox family transcription factors 
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(Sox9, Sox5, and Sox6) regulate chondrocyte differentiation, MyoD transcription factors 
(MyoD, Myf5, and myogenin) regulate myogenic differentiation, and C/EBP family 
(C/EBPb, C/EBPd, and C/EBPa) and PPARg2 transcription factors regulate adipocyte 
differentiation [197].  
In the case of mesenchymal cell differentiation into osteoblast lineages there is 
precedence for ROS stimulation to both direct and enhance this process [179, 194, 195]. 
Similarly, enhanced chondrogenesis has also been associated with ROS stimulation [191] 
and the occurrence of oxidative spikes as a driving force for transitional stages throughout 
developmental and regenerative processes is a commonly observed phenomena. 
 
 Mesenchymal Cell Differentiation  
Mesenchymal stem cells differentiate into immature osteoblasts, which express 
bone matrix protein genes, through the actions of Runx2, osterix, and b-catenin. The Runx 
family is composed of three genes, Runx1/Cbfa2/Pebp2aB, Runx2/Cbfa1/Pebp2aA, and 
Runx3/Cbfa3/Pebp2aC. Runx2 is essential for osteoblast differentiation [197]. 
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Figure 9: Mesenchymal Cell linages examples including chondrocytes (cartilage cells), osteoblasts (bone 
cells), adipocytes (fat cells), neurons and myoblasts (muscle cells). 
 
Osterix, which has three zinc finger motifs, belongs to the SP family transcription 
factors. Osterix/ mice show complete lack of osteoblasts, demonstrating that osterix is a 
second transcription factor that is essential for osteoblast differentiation [198]. Recently, 
the importance of Wnt signaling in bone formation was revealed [175, 199, 200]. Wnts 
activate the canonical pathway by interacting with receptors of the Frizzled family and co-
receptors of the LRP5/6 family. During differentiation immature osteoblasts express high 
levels of osteopontin then differentiate into mature osteoblasts, which express high levels 
of osteocalcin, and finally the mature osteoblasts are embedded in in the bone matrix and 
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become osteocytes. For bone formation to occur osteoblast precursors are recruited to sites 
of previous resorption; these cells then differentiate into matrix-producing cells that either 
become lining cells or preosteocytes embedded in the newly formed osteoid. Osteocytes 
are derived from the same precursors as osteoblasts and are recognized as terminally 
differentiated osteoblasts [197]. A mature osteocyte is defined as a cell surrounded by 
mineralized bone. Osteocytes compose over 90% of all bone cells [201]. MLO-A5 cell line 
has osteocyte like characteristics and the capacity to mineralize without the addition of β-
glycerophosphate (β-GP) or ascorbic acid. The MLO-A5 cell line is representative of the 
postosteoblast, preosteocyte cell (Figure 10). 
 
 
 
Figure 10: Events associated with osteogenic differentiation into mature osteoblast (bone). Early 
differentiation markers include fibroblast growth factors (FGF2), bone morphogenetic proteins (BMPs), 
Collagen 1, Runx2. Late differentiation markers include Bone sialoprotein (BSP), osteocalcin (OSTCN) and 
Osterix (OSTRX). 
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Cartilage formation is initiated first by the condensation of mesenchymal cells, 
followed by cell chondrocyte proliferation, prehypertrophy, and hypertrophy [202, 203]. 
Specific cytokines and growth factors are required including bone morphogenetic proteins 
(BMPs), fibroblast growth factors (FGFs), insulin-like growth factor (IGF) 1, and 
parathyroid hormone–related peptide (PTHrP) which regulate these steps in a spatially and 
temporally specific manner (Figure 11). During differentiation, chondrocytes secrete 
extracellular matrix (ECM) molecules characteristic of cartilage, such as collagens II, IX, 
X, and XI, aggrecan, and link protein, providing an environment that maintains the 
chondrocyte phenotype. Thus, chondrocytes are defined by both their morphology and 
capacity to synthesize these characteristic ECM molecules [204]. A cell line designated as 
N1511, differentiates into chondrocytes in response to BMP-2 and insulin or both PTH and 
dexamethasone. During differentiation, they express cartilage-specific ECM genes 
encoding cartilage specific collagens and aggrecan. 
 
 
Figure 11: Events associated with chondrogenic differentiation into mature chondrocytes (cartridge). Early 
differentiation markers include Runx2 and Alkaline Phosphatase (ALKP). Late differentiation markers 
include Collagen X (COL X) and MMP-13. 
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Enhancing chondrogenic and osteogenic differentiation is of paramount importance 
in providing effective regenerative therapies and improving the rate of fracture healing. 
Several models are used to investigate chondrogenic and osteogenic differentiation, which 
is detailed below.  
 
 Embryonic Limb Development 
When mesenchymal cells proliferate from the lateral plate of the mesoderm to the 
ectoderm, they form a limb bud to initiate limb formation. In the mouse, limb formation 
begins about 9 days post fertilization[166, 167]. The limb bud grows and organizes in less 
than three days with tendons, skeleton and dermis positions determined. The lateral plate 
cells produce the cartilaginous skeletal portions of the limb, while myotome cells generate 
muscle components.[167, 176] The limb bud remains active during limb development and 
it promotes formation of the apical ectodermal ridge (AER) and the zone of polarizing 
activity (ZPA) in the mesenchyme  [166, 167, 176, 205]. The AER is responsible for further 
limb development and controls cell death. Programmed cell death, also known as apoptosis, 
eliminates the webbing between the digits. The type of limb that will form is determined 
by the mesenchymal cells of the limb bud. Three major axes guide limb growth and 
patterning. The proximal-distal axis goes from the body to the fingertip. The anterior-
posterior axis goes from the thumb to the little finger. The dorsal ventral axis goes from 
the palm to the dorsal part of the limb. Limb growth and patterning is regulated by the 
coupled activity of the AER and ZPA regions [166, 167, 176, 205].  
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Organ culture of limb autopods is a process where growth, cell differentiation, and 
tissue organization of the amputated limb occurs in vitro [206-208].  Pattern formation of 
the mouse limb bud under culture conditions are well characterized. While limb 
development in culture occurs at a slower rate, compared to in vivo development, it follows 
the same pattern. Differentiation of cartilage and limb growth contribute to the formation 
of 3D proximal and distal structures. Limb culture has been used to study mechanisms of 
critical signaling pathways and to explore the roles of genes during embryogenesiss [209]. 
In the in vivo environment, the front limb buds appear between gestation day 9.5 and 10; 
while the hind limb buds appear between day 10 and day 10.5. Limb buds explanted on 
day 11 or 12 of gestation and cultured in a specially designed medium will continue to 
grow for 6–9 days [210]. The differentiation of the limb occurs in a proximal–distal axis, 
cranial–caudal axis and dorsal–ventral. During this time cell proliferation, migration, 
epithelial–mesenchymal interaction, and apoptosis takes place [209]. The morphological 
differentiation can be quantified by image analysis [211, 212]. Gene expression and protein 
markers can be analyzed and quantified [213-217]. In addition, numerous studies have 
investigated the signaling pathways involved in those processes [218]. A detailed protocol 
for limb culture technique can be found in [209]. Figure 12 shows in vitro culture of limbs 
explanted on day 11, day 12.5, day 14.5 and day 16. Hind limb development at day 11 is 
arrested as compared to the front limb. However, hind limb development catches up with 
front limb development at day 14.5.  
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Figure 12: In vitro culture of limbs that were explanted on day 11, day 12.5, day 14.5 and day 16. Noticeable 
changes in development between the fore and hind limbs are observed for day 11 and 12.5 while limbs 
explanted on day 14.5 and day 16 show similar development patterns for front and hind limbs. Taken with 
Olympus microscope at magnitude 2.5x. 
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 Safe, Controllable and Efficient Dielectric Barrier Discharge Sources 
for Application to Living Tissue  
3.1. Introduction 
Dielectric Barrier Discharge (DBD) technology has been used for the past 150 years 
in industry for ozone generation, pollution control, excitation of CO2 lasers, polymer 
surface modification, NT-plasma chemical-vapor deposition and more. Nevertheless, DBD 
applications for medicine and biology have been explored for little more than a decade. 
Safe and controllably generated NT-plasma with DBD for living cells and tissues became 
available due to exponential progress in pulsed power engineering and electronics. DBD 
can be ignited in atmospheric air, which makes it more cost effective and easy to implement 
compared to plasma jets, which are also being explored for medical applications. While 
sterilization of inanimate objects with non-thermal plasma might be achieved by several 
methods, including wide range of NT-plasma doses, different discharges and electrode 
sizes, application of NT-plasma directly to living organisms, cells and tissue requires 
delicate tuning. The modified microsecond-pulsed barrier discharge plasma source used in 
this work was characterized using optical emission spectroscopy and voltage-current 
measurements.  
As described in the background chapter, non-thermal plasmas are being extensively 
explored for medical applications, including studies on wound healing [61, 219, 220] blood 
coagulation [16] cancer [25], [127] and regeneration [221, 222]. A variety of non-thermal 
plasma discharges with different geometries have been studied. Some directly contact cells 
and tissues while others are applied indirectly to liquid which covers the cells or tissues. 
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While the mechanistic details of the NT-plasma / cell interaction remains unclear, both 
indirect jet plasmas and direct dielectric barrier discharge (DBD) plasmas have been 
successfully utilized in these studies. However, questions about determining dose and 
efficacy of NT-plasma treatments have arisen. How can discharges be scaled to 
successfully apply NT-plasma in a consistent manner with different NT-plasma types or to 
larger or smaller targets? Plasma jet applications are scaled by creating discharge arrays 
[223-225], while DBD applications allow a simple change of electrode size but can also 
operate in array.   
Comparing different NT-plasma treatments is challenging when the treatments are 
performed with different NT-plasma discharges, or even with the same discharge type, 
using a different power supply or different probe.  The current standard for comparison is 
to report the conditions based on a plasma dose which can refer to either Joules per unit 
area [J/cm2] or power density in Watt per unit area [W/cm2] [23, 226]. While plasma dose 
is convenient, there are several difficulties associated with its use. Usually, the calculations 
of NT-plasma dose are based on a measurement of NT-plasma average power per pulse, 
then multiplied by number of pulses during the treatment (frequency multiplied by time) 
and then divided by electrode area. The power is typically calculated using the current and 
voltage waveform recorded by oscilloscope. In the case of DBD while the voltage 
waveform is usually smooth, the current waveform has multiple, fast, dynamic spikes. 
Therefore, accurate measurement of power is not straight forward [227]. Parameters 
affecting NT-plasma dose include treatment time, frequency, voltage, current, pulse width, 
duty cycle, electrode size, discharge gap, discharge gas and electrode material. The 
question is whether each of these parameters are of equal importance in affecting biological 
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activity.  To date, this question has not been answered. To explore scaling of DBD electrode 
size and correlate these changes with cell/tissue responses, discharge energy, filament 
distribution and were measured for three electrode sizes and various NT-plasma 
parameters: frequency, gap between electrodes and treatment time. 
 
3.2. Materials and Methods 
 Modified Microsecond-Pulsed Dielectric Barrier Discharge Plasma 
Generator 
The microsecond power generator used for the experiments in this thesis was 
manufactured by Advance Plasma Solutions (Drexel Alliance Company) and is similar to 
the one previously described [16] (Figure 13). The power generator included high voltage 
insulated-gate bipolar transistor (IGBT) as a primary coil section, high voltage transformer 
and pulse control board.  
 
 
Figure 13: A) DBD power supply schematics and power analysis schematics [16]. B) Picture of the modified 
power generator. C) Foot pedal for ease of performance of biological experiments requiring sterile condition 
in a biological hood.  
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The modification to the current power generator [16] included digital control for 
impulse repeatability improvements (Figure 13B), accidental arcing protection and a duty 
cycle, which allowed high frequency application of up to 3500 Hz without overheating the 
tissue sample. Another modification was the addition of a foot pedal. The foot pedal 
allowed hands free generation of NT-plasma and was essential for experiments performed 
inside a biological hood, where maintaining sterile condition during NT-plasma treatment 
is extremely important (Figure 13C). 
The modified power supply allowed us to vary frequency between 50 and 3500 Hz 
and allowed us to change pulse width of the IGBT. High voltage rise time was 5 V/ns. 
These parameters were used to determine dose and dose rate suitable for biomedical 
application and allowed for a high repetition of the generated impulses. 
 
  Discharge electrodes 
Four electrode configurations with two different types of high voltage electrodes 
were used in all experiments. The first configuration is plane-to-plane with flat surface 
electrode, and the second configuration was a sphere-to-plane with a spherical electrode 
[16]. The modification of the current electrodes included a thinner quartz layer (0.5mm 
compared to 1mm) and smaller electrode area, which was needed for treatment of 
biological samples in culture dishes.  During the NT-plasma treatment of biological 
samples, the second electrode was the plastic cell culture dish containing either cells or 
autopods. The plastic dish was placed on a grounded metal plate. For discharge pictures, 
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grounded conductive glass was used as a second electrode. For power measurements, either 
grounded conductive glass or grounded metal was used.  
 Initially, different electrodes were used for different biological applications, 
depending on the desired target area. For autopod treatment a small wand electrode was 
used and for protein collection from cells treated with DBD a large planar electrode was.  
 
 
Figure 14: A) Photograph of discharge electrodes: from left – large area plane electrode, which fits 6-well 
culture dish; small area plane electrode, which fits 24-well culture dish; sphere (wand) electrode, fits 96- well 
culture dish. B) Electrode stand with z-positioner, which allows controlled regulation of the gap between the 
electrode and the treated sample.   
 
3.2.2.1 Planar Electrode 
Three plane-to-plane electrodes composed of an inner core of copper surrounded 
by an outer insulating shell of acrylic were used. The NT-plasma-generating surface was 
covered with a 0.5 mm quartz disc, (compared to the 1mm quartz disc that was previously 
used [16, 228]). The size reduction created a thinner dielectric reducing plasma power.  The 
largest electrode was chosen to fit a 6-well cell culture dish (Figure 14). It had an inner 
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diameter (i.d.) of 2.3 cm and an outer diameter (o.d.) of 3.8 cm. The active electrode area 
was 4.15 cm2. This electrode was referred in the text as the 6-well electrode. The middle 
electrode had an i.d. of 1.6 cm and an o.d. of 1.95 cm, which fit into a 12-well cell culture 
dish. The active electrode area was 2 cm2. This electrode was referred in the text as the 12-
well electrode. The smallest electrode had an i.d. of 1.03 cm and an o.d. of 1.25 cm which 
fit into a 24-well cell culture dish. The active electrode area was 0.83 cm2 (Figure 14). This 
electrode was referred in the text as the 24-well electrode. 
 
3.2.2.2  Sphere-to-plane electrode 
The sphere-to-plane electrode was a 5 mm wand electrode composed of an inner 
core of copper surrounded by an outer insulating shell of acrylic (Figure 14, Figure 15). It 
fit into a 96-well cell culture dish, thus it was referred in the text as the 96-well electrode.   
 
 
Figure 15: DBD plasma sphere-to-plane electrode (referred to as 96-well electrode) used for limb autopod 
stimulation 
41 
 
  Voltage and Current Signals 
 
 
Figure 16: Simplified equivalent circuit of the experimental set-up for measurement of the voltage and current 
curves. 
 
 
Electrical measurements have been conducted using a high frequency high voltage 
probe (P6015A, Calibrated. 20kVDC/40kV pulse, high voltage divider (1000:1) connected 
in parallel with the discharge and a high frequency current transformer (Rogowski coil ,Ion 
Physics Corp CM-10-L, 1 V/1 A, 5 kA max) around the high voltage electrode wire (Figure 
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16). Both probes were connected to a 10 feet coax cables to insure simultaneous recording 
of the voltage and current value. The probe signals were acquired with a Tektronix 
DPO4104B (1 GHz bandwidth, 5 GS/sec) at 1M points per pulse (Figure 17). Instantaneous 
current and voltage in the gap were measured and power dissipation in the discharge was 
analyzed. Recorded data was processed using a customized MATLAB (MATLAB & 
Simulink Student Version - Release 2013a, MathWorks, Natick, M) code which integrates 
the instantaneous power (V∗I) over one cycle to determine an average energy per cycle and 
average power. Ten measurements were recorded for each condition for statistical analysis 
and repeatability assessment.  
 
 
 
Figure 17: Oscillogram of a single pulse discharge of the power supply used in generation of the DBD. 
Conductive glass was used as a second electrode in plane-to-plane configuration. 
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  Optical Emission Spectroscopy 
Rotational and vibrational temperature of the DBD NT-plasma was calculated from 
measured optical emission spectrum. Spectograph Acton SP500i and WinSpec/32 software 
were used to record the optical spectrum. The spectrograph was equipped with a detector 
EEV 1024x1024 CCD47_10 X. Background was acquired in the mode where there was no 
discharge. The spectrum was collected using a Step and Glue grooves: 900, starting 
wavelength 200 nm, and ending at 800.026 nm. Minimum overlap was set to 5nm. Final 
Resolution was 0.0269602nm. Exposure time was adjusted based on the frequency to 
capture ~100 pulses. Figure 18 shows schematic measurement setup. 
 
SP500i
DBD electrode
Plasma
Grounded plate
Fiber-optic
 
Figure 18: Experimental set-up for determination of Optical Emission Spectrum 
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3.3. Characteristics of Microsecond Pulsed Dielectric Barrier Discharge for 
Biomedical applications 
 Electric Characterization 
To determine the contribution of various NT-plasma conditions to the electrical 
discharge characteristic, peak-to-peak voltage and current as well as maximum 
instantaneous power and mean discharge energy were evaluated. Power consumption 
measurement method was based on electric current method rather than electric charge 
method [227]. In the electric current method, a time dependent voltage and current signals 
were recorded. The two signals were then multiplied for calculation of the instantaneous 
power (Equation 3-1). The instantaneous power can then be integrated over one period T 
for calculation of the average power (Equation 3-2).  
 
Equation 3-1 : instantaneous power   
     
𝑷𝑷(𝒕𝒕) = 𝑽𝑽(𝒕𝒕)𝑰𝑰(𝒕𝒕) 
V(t) – is the voltage of the discharge;  I(t) – is the current of the discharge;  P(t) –  
instantaneous power. 
 
 
Equation 3-2 : Average power per pulse:  
𝑷𝑷𝒂𝒂��� = 𝟏𝟏𝑻𝑻� 𝑽𝑽(𝒕𝒕)𝑰𝑰(𝒕𝒕)𝒅𝒅𝒕𝒕𝑻𝑻𝟎𝟎  
T – is the wave period. 
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Figure 19: Voltage-current (V-I) curves vs time in a single pulse. Red arrow show the integration region 
used to calculate the energy per pulse.  
 
The voltage signal recorded in the oscillogram displays a smother curve with 
decaying maxima along the time axis (Figure 19). Typical microsecond pulse DBD NT-
plasma oscillogram exhibits many fast dynamic spikes in the current signal (Figure 19) due 
to multiple individual microdischarges. These current spikes were characteristically very 
short in duration and questions arise regarding the validity of using the measured current 
to calculate the discharge power [229]. Nevertheless calorimetric measurements based on 
a previous study [229] confirmed that power based on oscillogram analysis was accurate 
with error less than 7%. 
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Figure 20: Magnification of Figure 19. Each current spike indicates creation of microdicharges. The red 
arrow indicates the time region used to calculate the values of the mean energy per pulse. 
 
 
Figure 21: Example of instantaneous power as a function of time in a single pulse. 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1x 10-6-2-1.5
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Figure 19 and Figure 20 show current and voltage curves of discharge at a 
frequency of 1k Hz and pulse width of 10 µs for the with 6-well electrode. A ground 
aluminum plate was used as the second electrode. As shown in these figures, the current 
spikes last about 0.5 µs, peak to peak voltage is about 25 kV and peak to peak current can 
reach 3 A. Figure 20 shows that voltage local maxima and current spikes were slightly 
shifted in the time scale. Instant values for voltage and current were multiplied to determine 
instant power (Figure 21, Equation 3-1), which was then integrated using Matlab software  
over the entire cycle (Figure 20) giving the value of discharge energy per pulse. Ten 
measurements were taken for statistics analysis. Standard deviation is provided for all 
experimental data displayed. 
 
 
Figure 22: Reputability of I-V repetition measurements. 
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Equation 3-3: Discharge energy, E, per pulse:  
𝑬𝑬 = � 𝑽𝑽(𝒕𝒕)𝑰𝑰(𝒕𝒕)𝒅𝒅𝒕𝒕𝑻𝑻
𝟎𝟎
 
 
The red arrow (Figure 19) indicates the time region used to calculate the values of 
the mean energy per pulse. 
Figure 22 shows ten repeated measurements used for statistical analysis and 
demonstrate discharge repeatability. Figure 23 demonstrates repeatability of the 
instantaneous power in a single pulse. 
 
 
Figure 23: demonstration of power repetition measurement. 
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Figure 24 shows displacement current measured without NT-plasma ignition. NT-
plasma ignition was prevented by increasing the gap between high voltage and ground 
electrode. Figure 25 shows instantaneous power for displacement current in Figure 24. The 
average power for displacement current in Figure 24. The average power (Equation 3-2) of 
the displacement current was 0.5 mJ per pulse and it is approximately 25% of the average 
power when NT-plasma was ignited. 
 
 
Figure 24: Measurement of displacement current. 
 
0 0.5 1
x 10
-6
-0.10
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
0 0.5 1
x 10
-6
-0.1-0.0500.05
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
0 0.5 1
x 10
-6
-0.10
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
0 0.5 1
x 10
-6
-0.10
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
0 0.5 1
x 10
-6
-0.1-0.0500.05
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
0 0.5 1
x 10
-6
-0.1-0.0500.05
0.1
x 10
4
V
ol
ta
ge
 [V
]
Time (µsec)
C
urrent [A
]
50 
 
To investigate whether discharge frequency affects peak-to-peak voltage, NT-
plasma generator frequency was alter from 50 Hz to 3 kHz. This experiment was performed 
with 6-well flat electrode. ITO glass was used as a second electrode and the gap was set to 
2mm. 
 
Equation 3-4: Total discharge energy: 
𝑬𝑬 = 𝑭𝑭 ∗ 𝝉𝝉� 𝑽𝑽(𝒕𝒕)𝑰𝑰(𝒕𝒕)𝒅𝒅𝒕𝒕𝑻𝑻
𝟎𝟎
 
Where F is the Discharge frequency and τ - treatment time, T – pulse width. 
 
 
Figure 25: Instantaneous power of displacement current measurement. 
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Figure 26 compares electrical characteristic of the discharge as a function of 
frequency for two electrode gaps: 1 mm (blue) and 2 mm (orange). As can be seen from 
the figure, 1 mm electrode gap resulted smaller maximum peak-to-peak voltage (Figure 
26A) but higher maximum peak-to-peak current (Figure 26B) compared to 2mm gap at 
frequencies bellow 1 kHz. For 2 and 3 kHz frequencies both 1mm and 2mm gap showed 
similar results in terms of maximum peak-to-peak voltage and current. The frequency did 
not affect maximum peak-to-peak voltage for 1mm (Figure 26A) however, in the 2 mm 
gap higher frequency resulted in a lower peak-to-peak voltage compared to frequencies 
bellow 1 kHz. Opposite behavior was observed for the current: smaller peak-to-peak 
voltage was measured for low frequencies compared to high frequencies in the 2 mm gap. 
Maximum instantaneous power (Pmax) is displayed in Figure 26C. Electrode gap of 1mm 
shows no dependence of Pmax on frequency.  Electrode gap of 2mm shows no dependence 
of Pmax on frequency for frequencies up to 250 Hz, with Pmax lower than Pmax of 1mm 
gap by factor of two. However, for frequencies 1 kHz and more, Pmax significantly 
increases compared to lower frequencies and inhibits decreasing linear dependence on 
frequency. Nevertheless, the mean energy per pulse, Figure 26D, washes out all the above 
mention differences in NT-plasma conditions and  shows that the mean energy per pulse is 
approximately 2mJ independent of frequency and electrode gap. 
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Figure 26: Electrical characteristic of 6-well electrode comparing electrode gap of 1 mm (blue) and 2mm 
(orange). A) Maximum peak-to-peak voltage as a function of frequency. B) Maximum peak-to-peak current 
as a function of frequency. C) Maximum instantaneous power as a function of frequency. D) Mean discharge 
energy per pulse as a function of frequency. Ten measurements were taken for statistical analysis and the 
standard diviation is shown on the graphs. 
 
Statistical significance of different NT-plasma conditions for peak-to-peak voltage 
and current was assessed with Mann-Whitney U-test and the results are displayed in Table 
1. The upper triangular part of the table (above the blue diagonal) displays the statistical 
significance of the peak-to-peak voltage. Based on these results most of changes observed 
were statistically significant. Similarly, the lower triangular part of the table (below the 
blue diagonal) displays the statistical significance of the peak-to-peak current. Most of the 
changes in peak-to-peak current were statistically significant as well.  
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Table 1: Statistical significance assessment using Mann-Whitney U-test comparing max peal-to-peak voltage 
(upper triangular) and max peal-to-peak current (lower triangular) between different NT-plasma conditions. 
Red color shows p<0.05; Yellow color shows p<0.01; Green color shows p<0.001; 
 
 
Table 2 displays statistical significance of different NT-plasma conditions for 
maximum instantaneous power and mean energy per pulse. The upper triangular part of 
the table (above the blue diagonal) displays the statistical significance of the maximum 
instantaneous power. Most of the significant changes were observed between the 1mm and 
2mm gaps as well as within the 2mm gap for different frequencies. The lower triangular 
part of the table (below the blue diagonal) displays the statistical significance of the mean 
energy per pulse. As can be seen most of the changes were not statistically significant 
except for 1 kHz results of the 2mm electrode gap. 
 
Table 2: Results of Mann Whitney U test comparing maximum instantaneous power (upper triangular) and 
mean energy per pulse (lower triangular) . Red color shows p<0.05; Yellow color shows p<0.01; Green color 
shows p<0.001; 
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Similar measurements were repeated for the 96-well electrode and 24-well 
electrode with electrode gap of 2 mm. The mean energy per pulse measured for both 24-
well and 96-well electrode was approximately 2 mJ per pulse, independent of the 
frequency. These results were similar to the 6-well electrode and not significant difference 
was found between the conditions. 
 
Equation 3-5: Total discharge energy density 
𝑬𝑬 = 𝑭𝑭 ∗ 𝝉𝝉 ∫ 𝑽𝑽(𝒕𝒕)𝑰𝑰(𝒕𝒕)𝒅𝒅𝒕𝒕𝑻𝑻𝟎𝟎
𝑨𝑨
 
A- is the electrode area; F – discharge frequency; 𝝉𝝉- treatment time. 
 
 
 
Figure 27: Energy density for 10s treatment as a function of frequency comparing 6-well (blue diamond), 24-
well (orange square) and 96-well (gray triangle) electrodes. 
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Figure 27 shows the calculated total energy density in 10s treatment as a function 
of frequency for 6-well (blue diamond), 24-well (orange square) and 96-well (gray triangle) 
electrodes. The total energy density was calculated based on Equation 3-5. Since no 
difference was observed in the mean energy per pulse among the conditions, linear 
dependence of the energy density on frequency is observed for all electrodes 
(Equation 3-5).  
 
 Thermal Characterization of the NT-Plasma 
To determine the effect of different NT-plasma parameters on chemical and 
electrical characteristic of the NT-plasma discharge optical emission spectroscopy (OES) 
was employed. From the measured spectrum rotational and vibrational temperatures were 
calculated and compared to simulated results obtained with SpecAir software. Hydroxyl 
radical relative concentration was also calculated from the spectrum and compared between 
different NT-plasma conditions.  Figure 28 demonstrate the spectrum taken with 6-well 
electrode with frequency of 50 Hz and electrode gap of 2mm. Exposure time was set to 
2mm to optimize the signal to noise ration yet to avoid long measurement time. The 
discharge characteristic is similar along all 8 channels.  Figure 29 shows the average 
spectrum from Figure 28. 
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Figure 28: Example of the spectrum taken with 6 well electrode at 50 Hz with 2 s exposure, 2mm from the 
conductive glass. 
 
 
Figure 29: Averaged spectrum from Figure 28. 
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Figure 30: a) Magnification of Figure 29 from 300-480nm. A typical emission spectrum from the DBD 
discharge measure with 6-well electrode at 50 Hz with 2s exposure 2mm above conducting glass.  The 
following radiative decays are shown 𝑁𝑁2(𝐶𝐶3Π → 𝐵𝐵3Π)𝑎𝑎𝑎𝑎𝑎𝑎 𝑁𝑁2+(𝐵𝐵2Σ → 𝑋𝑋2Σ) with vibrational quantum 
numbers 𝜐𝜐′ − 𝜐𝜐′′assigned b) Vibrational energy level diagram for the N2 transitions represented by the shown 
spectrum. The transition arrows are arranged in sequences of constant Δ𝜐𝜐, vertically aligned with the 
respective spectral bands, taken from [230]. 
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Figure 31: Measured (blue) and calculated (red) spectra of nitrogen emission N2(C–B,0–0) for 6-well 
electrode at frequency of 1000 Hz and electrode gap of 2mm.  
 
Figure 30A shows magnification of the spectrum in Figure 29 with nitrogen second 
positive system N2+(BX) transitions. This is in agreement with spectrum from discharge 
capillary tube containing diatomic nitrogen gas, probed using the Ocean Optics-UV-VIS 
miniature spectrometer system [230].  
Thermal discharge characterization based on optical emission spectroscopy showed 
rotational temperature in the range of 350-380K and vibrational temperature was found to 
be in the range of 3300-3400K, both were in agreement with previous studies [231-236] 
(Figure 31).  
Figure 32 compares the frequency effect on the optical spectrum measured with a 
6-well electrode positioned 2 mm away from the grounded plate. From the spectrum the 
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vibrational and rotational temperatures of the DBDs in the NT-plasma volume were 
calculated using 375.4 nm and 380.4 nm vibrational lines and rotational structure at this 
region of the second positive system of molecular nitrogen, 𝑁𝑁2�𝐶𝐶3Π →
𝐵𝐵3Π� 𝑎𝑎𝑎𝑎𝑎𝑎 𝑁𝑁2+�𝐵𝐵2Σ → 𝑋𝑋2Σ� . Optical emission spectroscopy show that the rotational 
temperatures were 355K (±12.1) for the 6-well electrode at 50 Hz and exposure time of 2s 
(0.05 J/cm^2) at distance of 2mm between the electrodes and 372K (±3.7) at 1000 Hz (1 
J/cm^2). These results agree with previous findings [231-236]. 
 
 
Figure 32: Comparing 100 pulses achieved with frequencies of 50, 1000 and 2000 Hz with 6-well electrode. 
Shows minor changes in the spectrum. 
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Reduced electric field was calculated by comparing the intensity of spectrum lines 
at 391 nm and 337 nm based on a previously published method [237] (Equation 3-6). 
 
 
Figure 33: A) Calculated hydroxyl radical relative concentration from 309 nm spectrum line as a function of 
frequency for 6-well electrode. The results were normalized to the hydroxyl intensity at 50 Hz. B) Calculated 
hydroxyl radical concentration as a function of electrode distance for 6-well electrode. The results were 
normalized to the hydroxyl intensity at 1 mm. C) Calculated reduced electric field as a function of frequency 
for 6-well electrode. Electrode gap was set to 2 mm. D) Calculated reduced electric field as a function of 
electrode distance for 6-well electrode. The frequency was set to 1 kHz.  
 
Equation 3-6: Relationship between reduced electric field (E/N) and intensity ratio [237]: 
𝑅𝑅391
337
�
EN� = 46 ∙ A ∙ exp �−89 �EN�−0.5� ∙ 0.065 ∙ exp �−402 �EN�−1.5� 
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Figure 33 compares the intensity of spectrum line 309, which corresponds to 
hydroxyl radical for different frequencies (Figure 33A) and different electrode gap ((Figure 
33B) measured with a 6-well electrode. Results indicate that hydroxyl radical concentration 
increased as the frequency increased and it reached  a saturation level at 1000 Hz. A reverse 
relationship was observed between hydroxyl radical concentration and electrode distance, 
maximum hydroxyl radical production was observed at a distance of  1mm compared with 
longer distances between the electrodes.   
Reduced electric field was linearly dependent on frequency (Figure 33C) for the 6-
well electrode at a 2mm distance between electrodes. Significantly higher reduced electric 
field was observed for the 1mm electrode gap compared to 2 and 3 mm distances between 
the electrodes (Figure 33D). 
 
 
Figure 34: A) Calculated OH radical concentration for different size electrodes for frequency of 1 kHz and 
electrode distance of 2mm. B) Calculated reduced electric field as a function of frequency for 6-well 
electrode. 
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Figure 34 compares the concentration of hydroxyl radicals and reduced electric 
field for 96, 24 and 6-well electrodes. The highest hydroxyl radical concentration was 
observed using the 96-well electrode while the lowest concentration was observed using 
the 24-well electrode. Reduced electric field remained relatively constant between the 
different electrodes 
 
3.4. Discussion  
Microsecond-pulsed dielectric barrier discharge electrical and thermal 
characteristics were presented in terms of NT- plasma parameters: discharge gap, 
frequency and electrode size. It was found that the maximum peak-to-peak discharge 
voltage range was between 28 and 32 kV, as a function of discharge frequency and 
discharge gap. Maximum peak-to-peak voltage at a discharge gap of 1mm showed little 
dependence on frequency. Maximum peak-to-peak voltage at discharge gap of 2mm was 
frequency dependent in a linear manner at frequencies bellow 2 kHz, and remained 
constant for higher frequencies. Discharge gap of 1mm resulted in a smaller maximum 
peak-to-peak discharge voltage compared with 2mm. Larger difference was observed for 
smaller frequencies (bellow 2 kHz) while at frequencies of 2 kHz and above both 1mm and 
2mm results were similar in terms of maximum peak to peak voltage. Since NT-plasma 
generation requires electric field of 30kV/cm or 3kV/mm, difference of maximum peak-
to-peak voltage of ~3 kV is therefore expected for a discharge gap difference of 1mm and 
indeed observed for low frequencies. At high frequencies the difference between maximum 
peak-to-peak voltage between 1mm and 2mm gaps was significantly smaller. It might be 
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the result of a memory effect, where reactive species and ions remain in the discharge 
volume and add to the applied electric field [47, 238]. Since the volume of NT-plasma in 
the 1mm gap is smaller than in the 2mm gap, the accumulation of charge at frequencies 
above 2 kHz may not be enough to lower the required peak-to-peak voltage and resulting 
in no dependence for the maximum peak-to-peak voltage and higher frequencies.    
Maximum peak-to-peak current at low frequencies (50 and 250 Hz) lead to 
significantly higher current at 1mm gap compared with 2 mm and was frequency 
independent. However for higher frequencies (1 kHz and above) the maximum current 
showed reverse, linear, dependence on discharge frequency for both 1 and 2 mm electrode 
distances. Larger standard deviation was observed for the 2mm discharge at frequencies of 
1 kHz and above.  
The maximum instantaneous power shows no dependence on frequency for the 
1mm gap (12W). A 2mm gap shows approximately maximum instantaneous power of 5 W 
for frequencies of 50 and 250 Hz. This power is significantly lower than the 1mm gap at 
those frequencies. At 1 kHz the maximum instantaneous power at gap of 2mm was 65 W 
and then it linearly decreased with frequency up to 10 W at 3000 Hz. 
The averaged mean energy per pulse, the parameter that is often used to describe 
the NT-plasma dose for biomedical applications [10, 16, 239-241], was independent of 
discharge frequency, gap or electrode area and shape. This result suggests that the main 
portion of discharge energy is not consumed by NT-plasma discharge but is converted to 
heat. Therefore, NT-plasma energy dose is not a precise method to compare different 
discharge conditions for biological applications.  
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Microsecond-pulsed dielectric barrier discharge chemical characteristics showed 
higher hydroxyl radical production for frequency of 1 kHz compared to 50 Hz. In addition, 
the highest hydroxyl radical production was recorded for a discharge gap of 1mm and then 
decreased as the gap was increased. 96-well electrode showed more than 3 times higher 
OH production compared with the 24 and 6-well electrodes, probably due to larger NT-
plasma channel in the 96-well electrode that contributed to higher local discharge 
temperature. Reduced electric field showed linear dependence on discharge frequency and 
measured range was between 385 Td (50 Hz) and 450 Td (2 kHz). Reduced electric at 50 
Hz showed maximum electric field of 505 Td at discharge gap of 1mm and the reduced 
electric field have leveled off at 385 Td for 2 and 3 mm. No difference was measured 
between the different electrodes in terms of reduced electric field. 
Thermal discharge characterization based on optical emission spectroscopy had 
shown rotational temperature in the range of 350-380K and vibrational temperature was 
found to be in the range of 3300-3400K, both with agreement with literature [231-236] 
(Figure 31). It was found that low frequency with spherical electrode showed less emission 
intensity compared to the flat electrode and the spectrum was noisier compared to the flat 
electrode spectrum collected with the same parameters. Discharge frequency has no effect 
on the spectrum in the flat electrode but in the spherical electrode it was found that 
discharge at 50 Hz were less stable than at 1000 Hz. Thus, 50 Hz frequency with the 
spherical electrode is not recommended for biological treatment. 
To summarize, while no difference in mean energy per pulse was observed across 
all NT-plasma conditions, thermal and electric characteristics showed significant 
65 
 
differences that can result in different effects of NT-plasma parameters on biological 
functions. Chapter 8: will demonstrate their effect on the biological outcomes. 
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 Dielectric Barrier Discharge NT-Plasma Treatment Enhances Skeletal 
Cell Differentiation 
4.1. Introduction 
Enhancing chondrogenic and osteogenic differentiation is of paramount importance 
in providing effective regenerative therapies and improving the rate of fracture healing. 
This study investigated the potential of non-thermal atmospheric dielectric barrier 
discharge plasma (NT-plasma) to enhance chondrocyte and osteoblast proliferation and 
differentiation. Although the exact mechanism by which NT-plasma interacts with cells is 
undefined, it is known that during treatment the atmosphere is ionized generating 
extracellular reactive oxygen and nitrogen species (ROS and RNS) and an electric field. 
Appropriate NT-plasma conditions were determined using lactate-dehydrogenase release, 
flow cytometric live/dead assay, flow cytometric cell cycle analysis, and Western blots to 
evaluate DNA damage and mitochondrial integrity. It was observed that specific NT-
plasma conditions were required to prevent cell death, and that loss of pre-osteoblastic cell 
viability was dependent on intracellular ROS and RNS production. To further investigate 
the involvement of intracellular ROS, fluorescent intracellular dyes Mitosox (superoxide) 
and dihydrorhodamine (peroxide) were used to assess onset and duration after NT-plasma 
treatment. Both intracellular superoxide and peroxide were found to increase immediately 
post NT-plasma treatment. These increases were sustained for one hour but returned to 
control levels by 24 hr. Using the same treatment conditions, osteogenic differentiation by 
NT-plasma was assessed and compared to peroxide or osteogenic media containing β-
glycerolphosphate. Although both NT-plasma and peroxide induced differentiation-
specific gene expression, neither was as effective as the osteogenic media. However, 
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treatment of cells with NT-plasma after 24 hr in osteogenic or chondrogenic media 
significantly enhanced differentiation as compared to differentiation media alone. The 
results of this study show that NT-plasma can selectively initiate and amplify ROS 
signaling to enhance differentiation, and suggest this technology could be used to enhance 
bone fusion and improve healing after skeletal injury.  
 
4.2. Materials and Methods 
 Cell Culture  
The pre-osteocytic cell line MLO-A5 was obtained from Dr. Linda Bonewald and 
cultured using the method described previously [242]. To induce maturation for qRT-PCR 
experiments MLO-A5, cells were placed in osteogenic differentiation media (Dulbecco's 
Modified Eagle's Medium (DMEM) (Cellgro, Fisher Scientific, USA) with 10% Fetal 
Bovine Serum (FBS) (Invitrogen, Life Science Technologies, USA), and supplemented 
with 100 units/ml penicillin, 100 µg/ml streptomycin (Cellgro, Fisher Scientific, USA), 0.5 
mM beta glycero-phosphate and 100 μg/ml ascorbic acid (Sigma-Aldrich, St. Louis, MO) 
and incubated in 5% CO2 at 37oC with media changes every 2 days. N1511 mouse 
chondrocytes were obtained from Dr. Motomi Enomoto-Iwamoto. The cells were 
maintained in culture using the method described previously [204, 243]. Briefly, the cells 
were plated at a concentration of 50,000 cells/ml in -MEM containing 10% FBS, 0.2% 
L-glutamine, and penicillin/streptomycin. To induce maturation, after 24 h, the adherent 
cells were treated with 200ng/ml recombinant BMP2 (Alpha Diagnostic Intl., San Antonio, 
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TX). Assessment of the maturation was performed at day 5 by measuring alkaline 
phosphatase activity and the expression of chondrogenic markers.  
 
 Real Time-PCR for Differentiation Markers and Comparative Analyses 
Confluent cells in 6 well dishes were either treated with differentiation media (β-
GP), H2O2 (100 µM) or treated with 1000 Hz NT-plasma for 10 sec and harvested after 
24 h.  Alternatively, confluent cells from 6 well dishes were placed in differentiation media 
(MLO-A5 with β-GP or N1511 with BMP) 24 h before NT-plasma or sham-plasma control 
treatment and harvested after 24 h or 56 h. All harvested cells were washed with DEPC 
water before total RNA was isolated using the QiagenRNeasy® Mini kit (Qiagen, 
Valencia, CA). RNA yield was determined spectrophotometrically and integrity confirmed 
by gel electrophoresis. RNA was reverse-transcribed and then amplified using the 
SuperscriptTM One-Step RT-PCR with Platinum Taq® (Invitrogen, Carlsbad, CA) kit. PCR 
products were analyzed by 1.0% agarose gel electrophoresis. Template cDNA and gene 
specific primers were added to Fast SYBR Green master mix (Applied Biosystems, 
Carlsbad, CA) and mRNA expression was quantified using the MyIQ Real-Time PCR 
System (BioRad, Hercules, CA). The expression level of the housekeeping gene, β-actin 
was used to normalize the data presented. Melting curves were analyzed to verify the 
specificity of the RT-PCR reaction and the absence of primer dimer formation. Each 
sample is analyzed in duplicate and included a template-free control. All the primers (Table 
3) used were synthesized by Integrated DNA Technologies, Inc. (Coralville, IN). 
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Table 3:  PCR primer information. 
 
Primer Name Strand Primer Sequence 
actin  FWD gct aca gct cac cac cac a 
actin  REV tct cca ggg agg aag agg a 
Osteocalcin  FWD gac aaa gcc ttc atg tcc aag c 
Osteocalcin  REV aaa gcc gag ctg cca gag ttt g  
BMP2  FWD aag aag ccg tgg agg aac tt 
BMP2  REV ttc ccg gaa gat ctg gag tt 
BSP  FWD agg gag gca gtg act ctt ca 
BSP  REV aca ccc gag agt gtg gaa ag 
Runx2  FWD gcc ggg aat gat gag aac ta 
Runx2  REV gga ccg tcc act gtc act tt 
Fgf2  FWD agc ggc tct act gca aga ac 
Fgf2  REV gcc gtc cat ctt cct tca ta 
ALK PHOS FWD tat gtc tgg aac cgc act ga 
ALK PHOS REV cca gca aga aga agc ctt tg 
Col X FWD cgt gtc tgc ttt tac tgt ca 
Col X REV acc tgg tca ttt tct gtg ag 
MMP-13 FWD atc ctg gcc acc ttc ttc tt 
MMP-13 REV ttt ctc gga gcc tgt caa ct 
OSTERIX  FWD act ggc tag gtg gtg gtc ag 
OSTERIX  REV ggt agg gag ctg ggt taa gg 
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4.3. Results 
 Determining the Appropriate NT-Plasma Dose  
 
 
Figure 35: Cell death measured by nuclear PI incorporation at 24 h showed increased cell death in response 
to frequency 50 Hz, 3500 Hz (p<0.01) and H2O2 (p<0.001) (n=3). There was no significant cell death in 
response to frequency 1000 Hz. Statistical significance was determined by the Mann-Whitney U test for non-
parametric data; * or # (p<0.01) ** or ## (p<0.001) [222]. 
 
To investigate the appropriate NT-plasma dose, MLO-A5 osteoblastic cells in 6 
well plates were treated with NT-plasma for 10 s at a voltage of 20 kV and pulse width of 
10 µs), varying only the frequency at either 50, 1000, or 3500 Hertz (Hz). Controls included 
the NT-plasma electrode without power as a sham treatment, and H2O2 (100 µM) as a 
positive control for ROS. Cell death was determined 24 h after NT-plasma treatment using 
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a fluorescent flow cytometric live/dead assay. Less than 4% of the cells underwent cell 
death in response to NT-plasma treatment, although the 50 Hz (p < 0.05) and 3500 Hz (p 
< 0.05) treatments were significantly above control (Figure 35). H2O2 induced a slightly 
higher 5.6% increase in cell death (p < 0.01). Results for the 3500 Hz treatment, were an 
under estimate of cell damage, as large areas of the culture plate were devoid of cells 
immediately after treatment (Figure 36). Due to cell detachment this setting was not used 
in subsequent assays.  
 
 
Figure 36: Cell detachment was observed at 3500 Hz as shown by toluidine staining of cells after NT-plasma 
treatment [222].  
  
 
To further assess the 50 and 1000 Hz dose rates, MLO-A5 cell cytotoxicity was 
measured using lactate dehydrogenase (LDH) (Figure 37). At 24 h LDH release in response 
to 50 Hz was 5.1% (not significant; ns) and 1000 Hz was 7.7% (p < 0.01) above NT-plasma 
sham control. Both treatments were less than H2O2, which induced an 11.2% increase in 
cell death (p < 0.01). To prevent changes in intracellular oxidant levels, TEMPOL (6 mM) 
a membrane permeable scavenger of both ROS and RNS, was added 1h before NT-plasma 
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or H2O2 treatment [244, 245]. TEMPOL reduced the release of LDH in response to 1000 
Hz NT-plasma (ns) and significantly decreased LDH release in response to H2O2 (p < 0.01), 
indicating ROS/RNS are being generated in response to NT-plasma and cause cell damage.  
 
 
Figure 37: Cell viability after NT-plasma was assessed by a lactate dehydrogenase (LDH) release assay. 1000 
Hz and H2O2 both showed an increase in LDH release (p<0.01 and p<0.001). LDH release was reduced in 
the presence of TEMPOL for both H2O2 (p<0.01) and NT-plasma treatments (ns, n=3).  Statistical 
significance was determined by the Mann-Whitney U test for non-parametric data; * or # (p<0.01) ** or ## 
(p<0.001) [222]. 
 
To determine whether NT-plasma treatment affected cell proliferation (increased S 
phase) or caused DNA damage (blockage in G2), flow cytometric analysis of cell cycle 
phase was determined 24 hours after treatment of MLO-A5 cells with 50 and 1000 Hz NT-
plasma or H2O2 (Figure 38). No significant differences were observed in the G1, S or G2/M 
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phase after any treatment, indicating no increase in cell proliferation or blockage of the cell 
cycle due to DNA damage.  
 
 
Figure 38: No difference in cell cycle profile was observed between NT-plasma at 50 Hz or 1000 Hz as 
compared to sham control [222]. 
 
Additionally, Western blot analysis was performed to assess damage to DNA or 
mitochondrial membranes using antibodies to the histone2A variant (H2AX) and 
cytoplasmic cytochrome c, respectively (Figure 39). The 1000 Hz NT-plasma treatment 
dose was achieved by varying the time to include 10 s (4.08 J/cm2), 30 s (12.24 J/cm2) and 
60 s (24.48 J/cm2) dose. The 10 s dose did not induce DNA or mitochondrial damage within 
1 h after treatment, but damage after both the 30 and 60 s treatments was observed.  
Taken together the results show that NT-plasma treatment at 1000 Hz for 10 s did 
74 
 
not significantly reduce cell viability, alter the cell cycle or cause DNA or mitochondrial 
damage in MLO-A5 cells. Based on these findings the 1000 Hz, 10 s NT-plasma treatment 
was chosen as the NT-plasma optimal treatment.  
 
 
Figure 39: Western blots show no H2Ax or cytochrome c release in cells treated at 1000 Hz for 10s as 
compared to the 30 and 60 s NT-plasma treatments [222]. 
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 Production of Intracellular ROS in Response to NT-Plasma 
 
 
Figure 40: Intracellular O2-. levels were measured using fluorescent indicator MitoSox (n=3). Immediately 
post-treatment (POST-PL) and at 1 hr, 1000 Hz NT-plasma treated cells generated significantly increased 
amounts of O2-. (p<0.001) as compared to sham control or pre-treatment levels (PRE-PL). Amounts of O2- 
were decreased by 24 hr. NAC quenched the O2- increase POST-PL and at 1 hr (p<0.01-0.001). The results 
are expressed as the mean ± standard deviation. Statistical significance was determined by the Mann-Whitney 
U test for non-parametric data; * or # (p<0.01) ** or ## (p<0.001) [222]. 
 
 
 
To evaluate intracellular reactive species levels in response to NT-plasma at 1000 
Hz, 10 s, mitochondrial superoxide anion (O2-.) and cytosolic/mitochondrial H2O2 levels 
were measured using fluorescent indicators MitoSox and dihydrorhodamine (DHR), 
respectively. Measurements were done immediately post-treatment (POST-PL), at 1 h and 
24 h after NT-plasma and results were compared to sham controls (pre-plasma, PRE-PL). 
Immediately post-treatment and at 1 h, NT-plasma treated cells showed significantly 
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increased intracellular O2-. (Figure 40) and H2O2 generation (p < 0.001) (Figure 41) as 
compared to PRE-PL. Levels of both oxidants returned to PRE-PL levels by 24 h. The 
immediate increase in H2O2 may be due to ROS produced by NT-plasma but the extended 
detection indicates ROS are being actively produced in response to NT-plasma. 
  
 
Figure 41: Intracellular H2O2 levels were measured using fluorescent indicator dihydrorhodamine (DHR) 
(n=3). Immediately post-treatment (POST-PL) and at 1 hr, 1000 Hz NT-plasma treated cells generated 
significantly increased amounts of H2O2 (p<0.001) as compared to sham control or pre-treatment levels 
(PRE-PL). Amounts of H2O2 were decreased by 24 hr. NAC quenched the H2O2 increase POST-PL and at 1 
hr (p<0.01-0.001). The results are expressed as the mean ± standard deviation. Statistical significance was 
determined by the Mann-Whitney U test for non-parametric data; * or # (p<0.01) ** or ## (p<0.001) [222]. 
 
To confirm the production of ROS in response to NT-plasma treatment, MLO-A5 
cells were pretreated for 1 h with either NAC (200 µM), to maintain intracellular redox 
balance and interfere with ROS production [246] or TEMPOL (6 mM), a scavenger of ROS 
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as well as RNS. After pre-incubation with the inhibitor, the cells were subjected to NT-
plasma treatment at 1000 Hz for 10 s. NAC significantly inhibited the POST-PL and 
 
 
Figure 42: Intracellular O2-. levels were measured using fluorescent indicator MitoSox (n=3). Immediately 
post-treatment (POST-PL) and at 1 hr, 1000 Hz NT-plasma treated cells generated significantly increased 
amounts of O2-. (p<0.001) as compared to sham control or pre-treatment levels (PRE-PL). Amounts of O2- 
were decreased by 24 hr. Tempol quenched the O2- increase POST-PL and at 1 hr (p<0.01-0.001). The results 
are expressed as the mean ± standard deviation. Statistical significance was determined by the Mann-Whitney 
U test for non-parametric data; * or # (p<0.01) ** or ## (p<0.001) [222]. 
 
 1 h NT-Plasma increase in both O2-. (Figure 40) and H2O2 (Figure 41). TEMPOL 
also significantly inhibited the POST-PL and 1 h increase in O2-. (Figure 42), and it 
inhibited the POST-PL increase in H2O2 (Figure 43). To lesser extent TEMPOL inhibited 
the 1 h increase in H2O2 in response to NT-Plasma, and at 24 h H2O2 production was 
increased (p < 0.01).  
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Figure 43:  Intracellular H2O2 levels were measured using fluorescent indicator dihydrorhodamine (DHR) 
(n=3). Immediately post-treatment (POST-PL) and at 1 hr, 1000 Hz NT-plasma treated cells generated 
significantly increased amounts of H2O2 (p<0.001) as compared to sham control or pre-treatment levels 
(PRE-PL). Amounts of H2O2 were decreased by 24 hr. H2O2 levels in the TEMPOL (p<0.01) inhibitor group 
were significantly increased above control at 24 hr, presumably due to removal of baseline NO..  The results 
are expressed as the mean ± standard deviation. Statistical significance was determined by the Mann-Whitney 
U test for non-parametric data; * or # (p<0.01) ** or ## (p<0.001) [222]. 
 
One possible explanation for the decreased effectiveness of TEMPOL after 1 h and 
24 h after NT-plasma/TEMPOL treatment is that removal of NO. prevents its reaction with 
O2-. and the production of peroxynitrite (ONOO-). Thus, by scavenging NO. TEMPOL 
allows H2O2 to be generated from O2-., rather than ONOO-, indicating some  NO. is being 
generated although at significantly lower amounts compared to H2O2.  
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 NT-plasma Differentiation of Osteoblasts and Chondrocytes in vitro 
To determine if NT-plasma treatment influenced the differentiation of MLO-A5 
cells, alkaline phosphatase (ALKP), bone morphogenetic protein 2 (BMP2), bone 
sialoprotein (BSP) and fibroblast growth factor-2 (FGF-2) expression was evaluated by 
qPCR. We compared differentiation media containing β-glycerophosphate (βGP) to either 
NT-plasma or H2O2 treatment; used to evaluate the effects of redox. Both NT-plasma and 
H2O2 increased the expression of osteogenic genes above controls, which were 
undifferentiated cells sham treated with NT-plasma (Figure 44). ALKP expression was 
upregulated 3 (ns) and 11 (p<0.01) fold, respectively, and BMP2 and BSP were increased 
5 fold by 24 h (p<0.05). However, compared to the 14-23 fold increases induced by βGP 
alone (p<0.01), these changes were relatively small. FGF-2 expression, which is increased 
in endothelial cells in response to NT-plasma [228], was not affected in MLO-A5 cells by 
NT-plasma, H2O2 or βGP. These results indicate NT-plasma does not significantly promote 
osteoblast differentiation when compared to βGP, although it induces some differentiation 
specific protein expression.  
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Figure 44: Fold increases in the expression of alkaline phosphatase (ALKP), bone morphogenetic protein 2 
(BMP2), bone sialoprotein (BSP) and fibroblast growth factor-2 (FGF-2) in response to NT-plasma 
treatment, H2O2 or  β-glycerol phosphate (βGP) normalized to sham treated control cells after 24 hr. ALKP 
was upregulated 3- (NS) and 11-fold (p<0.01), respectively, and BMP2 and BSP were increased 5 fold 
(p<0.05). βGP increased expression 14-23 fold (p<0.01). FGF-2 expression was not affected by NT-plasma, 
H2O2 or βGP [222]. 
 
As NT-plasma treatment evoked only a weak induction of osteogenic gene 
expression, a potential synergism between βGP and NT-plasma was investigated. NT-
plasma treatment applied 24 h after incubation in βGP, induced a 2-7 fold increase in the 
expression levels of osteogenic markers BMP2 and ALKP above βGP alone (p<0.05) 
(Figure 45). The expression of osterix (ostrx), a key transcription factor for osteogenesis, 
was increased 15 fold (p<0.01). At 56 h after NT-plasma treatment, the late osteoblast 
markers, BSP and osteocalcin (OSTCN) were increased 17-24 fold above βGP-treated 
control (p<0.05).  
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To determine if the differentiation effect of NT-plasma was osteoblast specific, the 
N1511 chondrocyte cell line was subjected to the same NT-plasma treatment in the 
presence of BMP2 (200ng/ml), a known inducer of chondrocyte differentiation [204]. 24 
h after treatment, chondrocyte differentiation markers Runx2, ALKP were increased 3-6-
fold above BMP-treated controls (p<0.05) (Figure 46). By 56 h, collagen type X (Col X) 
and another late marker, matrix metalloprotease 13 (MMP13) were both increased 20 
(p<0.01) and 4-fold (p<0.05), respectively above BMP-treated control. 
 
 
Figure 45: After a 24 hr incubation in βGP NT-plasma was applied. 24 hr later there was a 2-7 fold increase 
in the induction of BMP2, ALKP (p<0.05) and Osterix was increased 15 fold (p<0.01) compared to βGP 
treatment alone. At 56 hr, BSP and osteocalcin (OSTCN) were increased 17-24 fold above βGP-treated 
control (p<0.05). The results are expressed as the mean ± standard deviation (n=2). Statistical significance 
was determined by the Wilcoxin Mann-Whitney test for non-parametric data; * (p<0.05), ** (p<0.01) [222]. 
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Figure 46: After a 24 hr incubation in BMP2 NT-plasma was applied. 24 hr later chondrocyte differentiation 
markers Runx2, ALKP were increased 3-6-fold above BMP-treated controls (p<0.05). By 56 h, collagen type 
X (Col X) and another late marker, matrix metalloprotease 13 (MMP13) were both increased 20 (p<0.01) 
and 4-fold (p<0.05), respectively above BMP-treated control. The results are expressed as the mean ± 
standard deviation (n=2). Statistical significance was determined by the Wilcoxin Mann-Whitney test for 
non-parametric data; * (p<0.05), ** (p<0.01) [222]. 
 
It was concluded from these studies that NT-plasma alone was not sufficient to 
initiate significant changes in cell differentiation. However, once differentiation had been 
initiated, NT-plasma enhanced osteogenesis and chondrogenesis at both early and late time 
points. 
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4.4. Discussion 
This study investigated the potential of NT-plasma to enhance both chondrocyte 
and osteoblast differentiation. Initially, the specific NT-plasma condition required to 
maintain cell viability were determined and both an immediate and long-term increase in 
intracellular ROS and RNS in response to NT-plasma was shown. Furthermore, it was 
demonstrated that NT-plasma enhanced the expression of differentiation specific genes by 
MLO-A5 in media without differentiation factors and in differentiation media, In media 
alone, the levels of expression were equal to those induced by H2O2, but not as effective as 
differentiation medium. However, when NT-plasma was applied 24 h after the cells were 
placed in differentiation media a synergistic enhancement of chondrogenic and osteogenic 
differentiation was observed.  
The NT-plasma generated ROS and RNS at the cell/environment interface initiates 
an immediate intracellular oxidative response (Figure 40-Figure 43). It is interesting to 
speculate that this reaction may mimic naturally occurring ROS-associated cell signaling 
known to be associated with stem cell differentiation, cell fate decisions and regeneration. 
Within the stem cell pool, quiescence and pluripotency is maintained by the repression of 
ROS generation [247, 248]. As such, mouse and human embryonic stem cells have 
immature mitochondria, reduced expression of OXPHOS enzymes, low metabolic activity, 
low oxygen consumption, decreased levels of ATP production [249], express modest levels 
of antioxidant enzymes [248] and have a high glycolytic flux [249]. In vivo, embryonic 
stem cells are maintained in hypoxic conditions (2 to 3%) before vascularization [250] and 
in vitro, low oxygen culture conditions promote maintenance of pluripotency [228]. Rapid 
changes in ROS production and oxidative status associated with vascularization, growth 
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factor binding, or increased mitochondrial biogenesis and activity, all promote cellular 
differentiation and determine cell fate [251].  
Our findings highlight the capability of NT-plasma to promote osteo and 
chondrogenesis. The mechanism(s) by which both proliferation and differentiation occur 
is dependent on both immediate and long-term signaling molecules. In the short term, O2-. 
and H2O2 are produced during the 10 s NT-plasma exposure, however their sustained 
increases at 1 and 24 h after treatment is due to intracellular ROS production. The most 
likely sources of the increased intracellular ROS are NADPH oxidase and mitochondrial 
production of O2-., H2O2 and NO. [250, 252]. All three are signaling factors known to 
participate in cellular proliferation and differentiation by directly activating ROS or RNS-
responsive proteins or indirectly by altering the redox status of the cell [253-266]. 
Specifically, MAP kinases are known to respond rapidly to ROS stimulation and these 
kinases control a wide range of cellular processes including: cellular differentiation, cell 
cycle control, cytokine and growth factor signaling, survival, hypertrophy and/or apoptosis 
[111-114]. 
ROS also promote downstream cellular responses by affecting the activity and 
expression of specific transcription factors [121, 267, 268]. In osteoblast progenitors, 
continuous production of low levels of H2O2 stimulates proliferation and augments their 
potential to differentiate into mature osteoblasts through up-regulation of Runx2 and 
osterix. [119]. In turn, these transcription factors promote ALKP and osteocalcin 
expression in differentiating osteoblasts. Similarly, in the current study, NT-plasma 
induced ROS production increased the expression of Runx2, osterix, ALKP and 
osteocalcin in pre-osteoblastic MLO-A5 cells.  
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Conflicting findings have been reported concerning the role of ROS in cell 
differentiation, but these discrepancies may be due to differing methodologies used for the 
generation of ROS and the delicate balance required for the appropriate response [266]. In 
a recent study comparing glucose oxidase continuous production of low levels of H2O2 to 
a single bolus of chemical H2O2, only glucose oxidase generated H2O2 promoted osteoblast 
differentiation [119]. This finding is not unexpected as the glucose oxidase system mimics 
cellular levels of H2O2 production. In the same way, a 10 s exposure to NT-plasma initiates 
low-level intracellular production of ROS. This emphasizes that both timing and ROS 
concentration are critical in directing cell function. In the same way, chondrocyte 
differentiation in response to NT-plasma may be directly linked to ROS induced expression 
of SOX-9 and Runx2, which control collagen and aggrecan expression [269]. In a related 
study, laser irradiation induced intracellular ROS production and enhanced SOX-9 
expression leading to chondrocyte differentiation and expression of collagen and aggrecan 
[270]. The roles of ROS in progenitor cell proliferation and differentiation described above 
may also be directly applicable to more complex tissue systems such as regenerating limbs 
or limb development. While very little has been reported on the direct contribution of ROS 
in the developmental process, it is well established that a majority of the required signaling 
molecules (BMPs, WNTs and FGFs) either directly signal through ROS or are indirectly 
controlled by ROS [200, 271, 272]. 
Current studies investigating NT-plasma report multiple effects can be induced in 
living cells and tissues [228]: these include increased cell proliferation [273], enhanced cell 
transfection [43, 152, 274], selective killing of cancer cells [275] and improved wound 
healing [72, 276]. The multiple effects can be attributed to the in vitro conditions selected 
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during cellular treatment with NT-plasma. Results of the current study highlight the use of 
NT-plasma as a tool to initiate a non-lethal oxidative cellular burst that promotes osteoblast 
differentiation. Furthermore, these findings suggest that ROS and RNS produced in 
response to NT-plasma influence signaling pathways that are responsible for cellular 
proliferation and differentiation. Thus, it would not be unreasonable to assume that NT-
plasma could be used to promote musculoskeletal cell differentiation and tissue 
regeneration.  
 
4.5. Summary 
It was observed that specific NT-plasma conditions were required to prevent cell 
death, and that loss of pre-osteoblastic cell viability was dependent on intracellular ROS 
and RNS production. Both intracellular superoxide and peroxide were found to increase 
immediately post NT-plasma treatment. These increases were sustained for one hour but 
returned to control levels by 24 hr. Although both NT-plasma and peroxide induced 
differentiation-specific gene expression, neither was as effective as the osteogenic media. 
However, treatment of cells with NT-plasma after 24 hr in osteogenic or chondrogenic 
media significantly enhanced differentiation as compared to differentiation media alone. 
The results of this study show that NT-plasma can selectively initiate and amplify ROS 
signaling to enhance differentiation, and suggest this technology could be used to enhance 
bone fusion and improve healing after skeletal injury. 
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 Dielectric Barrier Discharge Plasma Treatment Enhances Skeletal 
Growth  
 
5.1. Introduction 
The enhanced differentiation of mesenchymal cells into chondrocytes or 
osteoblasts is of paramount importance in tissue engineering and regenerative therapies. 
As described in Chapter 1: outgrowth regeneration is dependent on reactive oxygen and 
nitrogen species (RONS) production and signaling. These results are in concert with a 
recent report of ROS dependent tail regeneration in Xenopus and zebrafish [277, 278], 
which led us to investigate the ability of NT-plasma to promote mouse limb bud 
development. As shown in Chapter 4: NT-plasma treatment stimulated reactive oxygen 
species (ROS) -associated cell signaling to enhance both osteoblast and chondrocyte 
differentiation. Since NT-plasma produces and induces RONS [220], the hypothesis is that 
NT-plasma would promote limb autopod development. To test this hypothesis NT-Plasma 
was applied to mouse limb autopods. 
 
5.2. Materials and Methods 
 Animals  
Timed pregnant mice were ordered from Jackson laboratory to ensure that the 
embryos would be at E-12 to E-14. The mice had either a CD-1 genetic background or 
were β-catenin/TCF/LEF reporter transgenic mice (BAT-GAL transgenic mice - Tg(BAT-
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lacZ)) mice containing a lacZ gene under the control of 7 consensus LEF/TCF-binding 
motifs upstream of a minimal promoter of the Xenopus siamois gene [279]. Staining for β-
galactosidase on embryonic limbs was performed according to the standardized protocol 
by Lobe et al. (1999) [280]. All animals were euthanized according to NIH guidelines for 
the care and use of laboratory animals and all animal protocols were approved by the 
Institutional Animal Care and Use Committee (IACUC) at Thomas Jefferson University.  
 Explant Culture 
Limb autopods were explanted from embryos of gestational ages E12.5 and E14.5 
[281] and cultured for up to 6 days in Dulbecco's Modified Eagle's Medium (DMEM; 
Cellgro, ThermoFisher Scientific, USA) with 2% Fetal Bovine Serum (FBS) (Invitrogen, 
Life Science Technologies, USA), and supplemented with 100 units/ml penicillin,100 
µg/ml streptomycin (Cellgro, ThermoFisher Scientific, USA) using the method previously 
described [282]. The limbs were placed on a naylon membrane in 12 well plates. 220 µl of 
DMEM media was added to each limb. Approximately 1 hour after isolation, NT-plasma 
or sham plasma treatment was applied to the left or right limb autopod from the same 
animal. The following morning the culture medium was changed and 1% FBS was added. 
The medium (DMEM with 2% FBS) was changed daily thereafter for the 4-6 days of 
culture.  
 Inhibitors 
Inhibitors CPTIO, 300 µM (Enzo Life Sciences, Farmingdale, NY); NAC, 200 µM 
(Sigma-Aldrich, St. Louis, MO); Tempol, 6 mM (Sigma-Aldrich, St. Louis, MO were 
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added to the medium for one hour before NT-plasma treatment and refreshed with each 
daily media change. 
 NT-Plasma treatment 
 
 
Figure 47: Schematics of the NT-plasma electrode applied to limb buds. 
 
High voltage alternating polarity pulse of 20 kV magnitude (peak-to-peak) was 
applied to the quartz-insulating electrode placed 2 mm above the sample undergoing 
treatment. The NT-plasma frequency was 1000 Hz and pulse duration was 10 µs, with 
typical rise time of 5 V/nsec. The schematics and time varying voltage and current curves 
of the power supply (Plasma Power, LLC, Philadelphia USA) in the pulse wave regime 
used to generated NT-plasma were as reported by Fridman, et. al [16]. A 5 mm wand 
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electrode composed of an inner core of copper surrounded by an outer insulating shell of 
acrylic was used for all treatments (Figure 47) was also previously described by Fridman, 
et. al [16]. Immediately before treatment, the media was changed to phenol red free DMEM 
with no FBS (Cellgro, ThermoFisher Scientific, USA) after which the limb was transferred, 
on the membrane, to an empty 35 mm dish. The dish with the limb rested on a grounded 
metal plate with the electrode positioned 2 mm above and NT-plasma was applied for 10 
sec. Then the membrane with the limb was returned to its well containing phenol red free 
DMEM with no FBS. 
 Real Time-PCR for Differentiation Markers and Comparative Analyses 
Limb autopods were harvested 24 h or 144 h after sham or NT-plasma treatment.  
All harvested limbs were washed with Diethylpyrocarbonate (DEPC) water before total 
RNA was isolated using the QiagenRNeasy® Micro kit (Qiagen, Valencia, CA). RNA 
yield was determined spectrophotometrically and integrity confirmed by gel 
electrophoresis. RNA was reverse-transcribed and then amplified using the SuperscriptTM 
One-Step RT-PCR with Platinum Taq® (Invitrogen, Carlsbad, CA) kit. PCR products were 
analyzed by 1.0% agarose gel electrophoresis. Template cDNA and gene specific primers 
were added to Fast SYBR Green master mix (Applied Biosystems, Carlsbad, CA) and 
mRNA expression was quantified using the MyIQ Real-Time PCR System (BioRad, 
Hercules, CA). The expression level of the housekeeping gene, β-actin was used to 
normalize the data presented. Melting curves were analyzed to verify the specificity of the 
RT-PCR reaction and the absence of primer dimer formation. Each sample is analyzed in 
duplicate and included a template-free control. All the primers ( 
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Table 4) used were synthesized by Integrated DNA Technologies, Inc. (Coralville, 
IN). 
 
Table 4: PCR primer information (in addition to Table 3 in Chapter 4:). 
Primer Name Strand Primer Sequence 
col1a1 FWD tcc tgc tgg tga gaa agg at 
col1a1 REV tcc aga agg acc ttg ttt gc 
eNOS FWD tct tcg ttc agc cat cac ag 
eNOS REV cca gcc atg ttg gat aca ga 
SOST FWD gca agc ctt cag gaa tga tg 
SOST REV aca tct ttg gcg tca tag gg 
Col X FWD cgt gtc tgc ttt tac tgt ca 
Col X REV acc tgg tca ttt tct gtg ag 
MMP-13 FWD atc ctg gcc acc ttc ttc tt 
MMP-13 REV ttt ctc gga gcc tgt caa ct 
CAT FWD ttg aca gag agc gga ttc ct 
CAT REV tga ctg tgg aga atc gaa cg 
OSTERIX FWD act ggc tag gtg gtg gtc ag 
OSTERIX REV ggt agg gag ctg ggt taa gg 
 
The expression level of the housekeeping gene, β-actin was used to normalize the 
data presented. Melting curves were analyzed to verify the specificity of the RT-PCR 
reaction and the absence of primer dimer formation. Each sample is analyzed in duplicate 
and included a template-free control. All the primers ( 
Table 4) used were synthesized by Integrated DNA Technologies, Inc. (Coralville, 
IN). 
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  Histology 
Tissue samples were fixed overnight in 4% paraformaldehyde, dehydrated in a 
graded series of alcohols and infiltrated and embedded in paraffin. Sections were cut at 6 
μm, mounted on slides (Superfrost/Plus; Thermo Fisher Scientific Inc). Standard histology 
including Hematoxylin, Eosin and Alcian blue was performed. 
 
 Statistical Analysis  
Statistical analysis between groups was performed using a one way ANOVA for 
normality and student’s t-test for continuous variables. A level of significance (α), or a p-
value of less than 0.05, with a 95% confidence interval was determined. Representative 
data are presented as the mean ± SEM of individual samples from 2 to 16 independent 
analyses. For non-parametric data, Mann Whitney U tests were used to evaluate 
differences. 
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5.3. Results 
 Grading Scale for Assessing Limb Autopod Survival, Growth and 
Elongation. 
 
 
Figure 48: Grading scale that assesses autopod digit development and growth. E 12.5 autopod was stain with 
alcian blue to visual cartilage elements. 1  = Stunted ;  2 – 4  = Surviving; 3 – 4 = Growth ;  4 = Elongation. 
 
 
Numeric grading scale of 1 through 4 was developed to assess limb autopod 
survival, growth and development (Figure 48). A score of 1 indicates stunted growth (lack 
of survival) with no defined cartilage segments. A score of 2 indicates the autopod has 
survived, developed the first two distinct cartilagenous joint segments. A score of 3 
indicates the autopod has undergone growth, developed three joint segments, and the 
metatarsal or metacarpal is approximately equal in length to the proximal phalange. A score 
of 4 indicates the autopod has undergone growth and elongation, has three or more joint 
segments, and the metatarsal or metacarpal is longer than the proximal phalange. The 
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scores between contralateral pairs were calculated to determine the effectiveness of NT-
plasma vs sham treatment (higher scores indicate more enhanced growth and 
development). Validation that contralateral limbs in organ culture perform equivalently 
was determined by evaluating 10 contralateral autopods cultured for 6 days without 
treatment. Figure 49 (left) shows that 91% of the time there was no significant difference 
between bilateral limbs (p = 1.00). Similarly, validation that plasma treatment of 
contralateral limbs in organ culture perform equivalently was determined by evaluating 10 
contralateral autopods cultured for 6 days after plasma treatment of 10 s was performed on 
both of the limbs on day 0. As indicated in Figure 49, in 70% of the cases there was no 
significant difference in their growth (p = 0.7). 
 
 
 
 
Figure 49: Based on the grading scale in Figure 48:, bilateral (right versus left) development of limbs from 
the same embryo was compared and showed relatively equal growth (p=1.0). 
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 NT-Plasma Enhances Limb Autopod Survival, Growth and Development  
5.3.2.1 E 12.5 Autopod 
To ascertain whether NT-plasma promotes growth and development of embryonic 
tissue, E12.5 mouse autopods were treated with NT-plasma and maintained in culture for 
up to 6 days. Figure 50A shows representative, consecutive images of NT-plasma enhanced 
digit development in an E12.5 autopod compared to its contralateral sham control (left 
treated with plasma vs right sham-treated control forelimbs or hind limbs). In developing 
embryos, hind limb maturation is delayed as compared to forelimb, by approximately 1 
day. For example, cartilaginous development evaluated using alcian blue staining to show 
digit definition, length and joint space illustrates the initial digit segmentation occurs at 24 
hr in the forelimb as compared to 48 hr the hind limb (Figure 50B). At these time points, 
NT-plasma treated autopods showed increased lengthening of the distal segments, 
signifying accelerated digit growth of the fore and hind limbs when compared to sham 
controls. At 48 (forelimb) and 72 hr (hind limb), all digit segments were noticeably more 
defined, longer and wider in response to NT-plasma treatment. At 72 hr (forelimb) and 96 
hr (hind limb), NT-plasma treated autopods displayed an additional distal segment with the 
appearance of the final joint space. In addition, at 144 hr both the NT-plasma treated fore 
and hind limbs were noticeably larger, while the sham treated autopods had stopped 
growing. Quantification of contralateral autopod growth showed that NT-plasma treatment 
promoted enhanced growth of 76% of the autopods as compared to only 5% after sham 
treatment (Figure 51: A; n = 21; p = 0.003). Only nineteen percent of the limbs showed no 
difference between sham and NT-treatments. 
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Figure 50: A) Consecutive images of NT-plasma enhanced (left) digit development in an E12.5 autopod 
compared to its contralateral sham control (right) B) Alcian blue (cartilaginous elements) stained fore and 
hindlimb autopods at 1 hr, 24hr, 48hr, 72hr and 144hr after NT-plasma or sham control treatments, highlights 
enhancement of digit definition, length and joint space by NT-plasma treatment.  
 
 
   
 
Figure 51: A) Contralateral limb grading result at 144 hours comparing sham and NT-plasma treatment of E 
12.5 autopod (n = 21) shows  that in 76% of the limbs NT-plasma promotes limb development (p = 0.0003). 
B) Limb grading results at 144 hours comparing sham (n = 73) and NT-plasma treatment (n = 61) of E12.5 
autopod shows  a 20% decrease in stunting and a 22% increase in elongated growth with NT-plasma treatment 
as compared to Sham.  
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Quantification of autopod development, based on the numeric grading described 
in 5.3.1, showed that plasma treated (E 12.5) autopods (n = 61) showed significantly 
superior outcomes for survival (p = 0.01), growth (p = 0.007) and elongation (p = 0.0003) 
as compared to sham control (Figure 51: B; n = 73). 
 
5.3.2.2  E 14.5 Autopod 
To ascertain whether NT-plasma assisted growth and development of embryonic 
tissue is stage specific, E14.5 mouse autopods were treated with NT-plasma and 
maintained in culture for up to 6 days. Figure 52 shows representative, consecutive images 
of NT-plasma enhanced digit development in an E14.5 autopod compared to its 
contralateral sham control (left treated with plasma vs right sham-treated control forelimbs 
or hind limbs). 
 
 
Figure 52: Consecutive images of NT-plasma enhanced (left) digit development in an E14.5 fore autopod 
compared to its contralateral sham control at 24hr, 48hr, 72hr and 96hr and alican blue staining at 120hr. 
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Figure 53 shows grading results of E 14.5 autopod. NT-plasma treatment promoted 
enhanced growth of 60% of the autopods as compared to 23% after sham treatment (Figure 
53A; n = 30; p = 0.03). Seventeen percent of the time there was no difference between the 
two treatments. Scoring of E14.5 autopods compared to sham control (n = 73) showed NT-
plasma treated autopods had a significantly better outcome for elongation (p = 0.001) 
(Figure 53B). Comparing the effect of plasma on autopod development of E12.5 and E14.5 
we see that plasma has a stronger effect on E12.5 autopods in terms of limb development 
(76% in E12.5 vs. 60% in E14.5). On the other hand, plasma had no significant effect on 
limb survival at E14.5, while it significantly enhances survival in E12.5 limbs. As of note, 
E14.5 sham showed higher stunted limb rate (38%) compared to E12.5 sham, possibly due 
to the size of the limbs that made it more difficult for the nutrients to pass the skin. As of 
limb elongation, plasma treatment resulted in more elongated limbs compared to the sham 
in both E12.5 and E14.5 autopods (22-23%).  
 
 
Figure 53: A) Contralateral limb grading result at 144 hours comparing sham and NT-plasma treatment of 
E14.5 autopod (n = 30) shows  that in 60% of the limbs NT-plasma promotes limb development (p = 0.029). 
B) Limb grading results at 144 hours comparing sham (n = 135) and NT-plasma treatment (n = 39) of E14.5 
autopod shows  a 5% decrease in stunting and a 22% increase in elongated growth with NT-plasma treatment 
as compared to Sham.  
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5.3.2.3 E 16.5 Autopod 
When the same experiments were repeated with E16 (Figure 54) embryo limbs, a 
less dramatic but still significant increase in growth was observed after NT-plasma 
treatment. NT-plasma treatment promoted enhanced growth of 50% of the autopods as 
compared to 23% after sham treatment (Figure 54B; n = 5). Since E16 limbs already have 
three digit segments in a very early stage, by 120h if the autopod thrive, then it reached 
numeric score 4.  
 
 
 
Figure 54: A) Consecutive images of NT-plasma enhanced (left) digit development in an E16.5 forelimb 
autopod compared to its contralateral sham control at 1h, 24h, and 120 h and alican blue staining at 120h. B) 
Contralateral limb grading result at 120 hours comparing sham and NT-plasma treatment of E16.5 autopod 
(n = 5) shows that in 50% of the limbs NT-plasma promotes limb development. 
 
 
To summarize, plasma promoted autopod survival, growth and elongation 
compared to sham treatment in autopods stages E12.5-E16.5. Although the most dramatic 
100 
 
effect is observed for plasma treatment of E 12.5 autopods, plasma continues to promote 
elongation up to E 16.5.  
 
5.4. Discussion 
This study investigated the potential of NT-plasma to enhance limb autopod growth 
and development. It was found NT-plasma treatment promoted both growth and 
differentiation of cartilaginous elements within the embryonic mouse autopod. Although 
the strongest effect was observed for E12.5 autopod, plasma promoted growth and 
development in all stages between E 12.5-E16.5. These findings highlight the potential of 
this new technology to specifically initiate cellular signaling cascades within developing 
tissue. Additionally, the autopod experiments demonstrate a single well-timed treatment 
with NT-plasma can augment a highly complex network of cellular interactions 
contributing to accelerated limb development.  
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 Non-Thermal Plasma Effect on Developmental Pathways 
 
6.1. Introduction  
 
As was demonstrated in 0 , non-thermal plasma promotes limb autopod survival, 
growth and development. As was also mention in the background chapter, intracellular 
RONS play important role in regeneration process. A recent report of iRONS dependent 
tail regeneration in Xenopus and zebrafish [277, 278], which led us to confirm the ability 
of NT-plasma to increase reactive oxygen species in the limb epidermis. As parallels are 
known to exist between functionality of the blastema in regeneration and the apical 
epidermal ridge (AER) in development, we hypothesized that NT-plasma treatment would 
enhances growth signaling pathways that are RONS dependent in the AER of each digit to 
increase growth. 
Vertebrate limbs grow through the coordinated activity of numerous growth factor 
signaling pathways, including the Wnt, FGF, bone morphogenetic protein (BMP), Notch 
and TGF-ß pathways [282-286]. iRONS play a primary role in mediating the activity of 
these factors and/or are integrally involved in regulating downstream signaling pathways 
[287]. For example, a sustained increase in iRONS levels is required for Wnt ß-catenin 
signaling and the activation of one of its main downstream targets, fgf20 [288, 289]. 
Additionally, naturally occurring oxidative spikes are observed in most of the transition 
stages throughout developmental and regenerative processes [251, 290]. Furthermore, 
there is precedence for ROS production to both direct and enhance mesenchymal cell 
differentiation into either chondrocyte or osteoblast lineages [291-293].  
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6.2. Results 
6.2.1.1 Increased Chondrogenesis after NT-Plasma Treatment 
To ascertain whether the enhanced growth observed was due to normal or aberrant 
chondrogenesis we stained sections of the limb autopods with H&E and Alcian blue. 
Morphological formation of the joint region and alcian blue staining of proteoglycan 
appeared normal in sham and NT-plasma treated digits (Figure 55A). Chondrocytes in the 
proximal segment of the sham-treated digit were entering the pre-hypertrophic stage, based 
on the larger size, greater cellular spacing, and decrease in proteoglycan (white triangle). 
This typically precedes the formation of the primary center of ossification in the diaphysis. 
In contrast, chondrocytes from the NT-plasma treated digit were immature and contained 
large amounts of proteoglycan. Even more striking was the much larger cartilage 
phalangeal segments in the NT-plasma treated digit. A white line with double arrows marks 
the joint between the first and second phalanges in both sections. In the sham treated digit, 
the adjacent joint spaces (white arrow) can be clearly observed, whereas in the NT-plasma 
treated digits there is no evidence of the next joint space, due to the increased segment 
length.  
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Figure 55: Histology and quantitative RT-PCR were used to assess chondrogenesis and molecular events 
associated with the accelerated development. A) H & E and Alcian blue stained sections of the middle 
phalanges from sham and NT-plasma treated limb autopods after 144 hr in organ culture. A white double 
arrow line marks the first joint space and highlights longer segment length in NT-plasma treated digit. The 
white arrows mark adjacent joint spaces and the white arrowhead pre-hypertrophic chondrocytes in the sham 
control.   B) At Day 1 post NT-plasma, ALKP, catalase (CAT), endothelial nitric oxide synthase (eNOS) and 
BMP2 expression was increased 2-fold above control (p < 0.05). BMP4 and Runx2 were increased 12-fold 
and 8-fold, respectively (p < 0.05), whereas FGF-2 showed no increase. More significant increases were 
observed at day 6 for ALKP (6-fold), CAT (14-fold) and BMP2 (3.5-fold)(p < 0.05). eNOS remained 
increased 2-fold above control at day 6, and both BMP4 and Runx2 showed a relatively consistent elevated 
expression at days 3 and 6. Up-regulation of chondrogenic transcripts confirms morphologic changes 
associated with chondrocyte differentiation, and the increased expression of CAT correlates with the 
importance of antioxidant expression within the digit for cell proliferation, growth and differentiation (15). 
The results are expressed as the mean ± standard deviation (n = 2-4; 2 limbs pooled per sample). Statistical 
significance was determined by the Wilcoxin Mann-Whitney test for non-parametric data; * (p < 0.05). 
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Quantitative RT-PCR was used to assess molecular events associated with the 
accelerated development in response to NT-plasma (Figure 55B). In E12.5 autopods at 1 
day post NT-plasma treatment, alkaline phosphate (ALKP), catalase (CAT), endothelial 
nitric oxide synthase (eNOS) and BMP2 expression were increased 2-fold above control 
(p < 0.05). BMP4 and runt-related transcription factor 2 (Runx2) were increased 12-fold 
and 8-fold, respectively (p < 0.05), whereas FGF-2 showed no increase. Even more 
significant increases were observed at day 6 for ALKP (6-fold), catalase (14-fold) and 
BMP2 (3.5-fold) (p < 0.05). eNOS remained increased 2-fold above control at day 6, and 
both BMP4 and Runx2 evidenced consistent elevated expression at days 1 and 6. Up-
regulation of chondrogenic transcripts confirmed the morphologic changes associated with 
chondrocyte differentiation in the autopod. The increased expression of CAT emphasized 
the importance of antioxidant expression within the digit for cell proliferation, growth and 
differentiation [294]. 
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 Immediate response to NT-Plasma Treatment 
 
6.2.2.1 NT-plasma Treatment Increases H2O2 Production by Cells within 
the Limb Autopod 
 
To directly assess the production of ROS by limb cells, E12.5 autopods were 
stained with dihydrorhodamine (DHR), a dye that becomes fluorescent after reaction with 
hydrogen peroxide. Figure 56 shows representative images 1 day post sham or NT-Plasma 
treatment. The transmitted light image (Figure 56A) shows the limb autopod features at 
this time point. Image of unstained limb (without DHR) at day 1 is shown to verify 
specificity of dye (Figure 56B). This image shows low level autofluorescence of collagen, 
while in both the sham (Figure 56C) and NT-plasma (Figure 56D) treated autopods H2O2 
positive cells are localized to the interdigital region as well as throughout the epithelial 
surface. H2O2 positive cells in these regions are consistent with localized cellular apoptosis 
as the limb grows and the digits separate. Of note, as the cells within the epithelium are 
translucent, positive cells observed in these images are present not only at the surface but 
several hundreds of microns into the tissue. Additionally, the NT-plasma treated autopod 
contains a layer of H2O2 positive cells lining the cartilaginous digits that are not observed 
in the sham control (white arrows). 
Representative images comparing the presence of H2O2 positive cells at the digit 
tip in sham and NT-plasma treated limbs at day 1 are shown in Figure 57. In response to 
NT-plasma treatment, an increased number of H2O2 producing cells were observed in the 
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tip region of each digit at day 1. These cells were localized behind a specialized region 
known as the apical epidermal ridge (AER) where mesenchymal cells receive signals from 
the AER directing their differentiation into chondrocytes. 
 
 
Figure 56: A) The transmitted light image shows the E12.5 limb autopod features of Day 1 limbs. B) Autopod 
image at Day 1 without DHR staining (Unstained). C) Fluorescent image of autopod stained with DHR 1 day 
after sham treatment. D) Fluorescent image of autopod stained with DHR 1 day after NT-Plasma treatment.  
 
 
Figure 57: H2O2 positive cells at the digit tip in sham (left) and NT-plasma (right) treated limbs at day. 
107 
 
6.2.2.2 Increased Wnt-signaling in the AER and Presumptive Joints after 
NT-Plasma 
 
To determine if signaling activity is also increased at the AER in response to NT-
plasma and H2O2 production, E12.5 contralateral limb autopods from the Bat LacZ Wnt-
signaling reporter mouse were treated with NT-plasma or sham treated. To visualize the 
expression and distribution of wnt, the limbs were stained with lacZ (blue). Day 1 after 
NT-plasma treatment, enhanced lacZ staining is evident in the posterior thumb region 
(white circle); where wnt is known to function as a regulator of anterior-posterior 
patterning (Figure 61) [295]. 
 
 
Figure 58: Enhanced Wnt signaling is seen in the E12.5 autopod from the top flash Wnt-signaling reporter 
mouse at day1. 
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 Long Term Effects of NT-Plasma Treatment 
Figure 59 shows representative day 6 post sham (A) or NT-plasma treatment (B). 
By day 6 a characteristic overgrowth of epithelium is observed in the sham control, 
visualized by the cloudy green autofluorescence of collagen in the epithelium. In contrast, 
the NT-plasma treated autopod shows bright punctate fluorescence of individual H2O2 
positive cells. A patterning of these cells is observed within the interdigit regions and 
throughout the less developed epithelium (white arrows). The high magnification image of 
the NT-plasma treated area shows initial healing of the treated area (white triangles) and 
the presence of H2O2 positive cells.  
 
 
Figure 59: A) Fluorescent image of autopod stained with DHR on Day 6 after sham treatment. B) Fluorescent 
image of autopod stained with DHR on Day 6 after NT-Plasma treatment. The image shows that the cells 
immediately surrounding the site of plasma application continue to generate H2O2 after a single 10 sec NT-
plasma treatment. 
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Representative images comparing the presence of H2O2 positive cells at the digit 
tip in sham and NT-plasma treated limbs at day 6 are shown in Figure 60. By day 6, a 
significantly lower number of H2O2 positive cells are observed in NT-plasma treated limbs 
(Figure 60 left). 
 
 
Figure 60: H2O2 positive cells at the digit tip in sham (left) and NT-plasma (right) treated limbs at day 6.  
 
 Increased Wnt-signaling in the AER and Presumptive Joints after NT-
Plasma 
Figure 61 shows lacZ (blue) staining of a Wnt-signaling reporter at day 2 and day 
5 mouse after sham (top) or NT-plasma (bottom) treatment. Day 2 after treatment, digit 
separation is more evident, and the AER of each digit stains more intensely for lacZ in 
response to NT-plasma compared to sham control (black arrows). At day 5, AER Wnt 
staining remains elevated in the NT-plasma treated autopod and digit separation and 
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elongation is more evident in these limbs. Joints are also beginning to form at this stage 
and can be identified by early Wnt signaling (white arrows) in the presumptive joint spaces. 
The NT-plasma treated autopod clearly shows an increased number of joints compared to 
sham controls, indicating accelerated maturation of the cartilage anlage. 
 
 
Figure 61: Enhanced Wnt signaling is seen in the E12.5 autopod from the top flash Wnt-signaling reporter 
mouse. 
 
 Antioxidant Stunting of Limb Autopod Development is Partially Rescued 
by NT-Plasma 
Inhibitors were used to evaluate the role of ROS and RNS in mediating NT-plasma 
accelerated E12.5 mouse autopod development (Figure 62). NAC (200 µM) was used to 
maintain intracellular redox balance [246], 2,2,6,6-tetramethyl-4-hydroxypiperidine 
(TEMPOL, 6 mM) a membrane permeable scavenger of both ROS and RNS, was used to 
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prevent changes to intracellular oxidant levels [244, 245], and 2-4-carboxyphenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide, (CPTIO, 300 µM) [296] was used as a chemical 
scavenger of nitric oxide (NO.). Autopod morphogenesis was stunted by the pretreatment 
of the limbs with each antioxidants, confirming the importance of ROS and RNS in 
development. Inhibition of both ROS and RNS by TEMPOL completely stunted autopod 
development. Whereas, removal of RNS by CPTIO had the least effect and mediation of 
ROS by NAC showed an intermediate effect. Interestingly, NT-plasma treatment partially 
rescued development moderately enhancing digit morphogenesis even in the presence of 
these anti-oxidants.  
 
 
  
Figure 62: Pretreatment of E12.5 autopods with redox (NAC), ROS and RNS (Tempol) or RNS (CPTIO) 
inhibitors stunts autopod morphogenesis. Treatment with NT-plasma partially rescues development, 
moderately enhancing digit morphogenesis compared to sham control. 
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  Epithelium thickening 
To determine if epithelium inhibition is partially responsible in autopod response 
to NT-plasma treatment, E18 limbs were stripped from their skin and cultured for 5 days 
in vitro. Figure 63 reveals that sham treated skinless limbs continue to grow and elongate. 
Sham control of limbs with intact skin on the other hand; demonstrate overgrowth of 
epithelium, as note in the previous section. NT-plasma treatment applied to skinless limb 
shows even higher limb elongation and growth, while NT-plasma treatment applied to 
limbs with intact skin shows better growth and elongation compared to sham treatment of 
limbs with intact skin, but lower growth relative to sham skinless autopod.  
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Figure 63: A) Images of E 18  autopod on Day 0, Day 3 and Day 5 . Right forelimb was sham treated and 
left forelimb was NT-plasma treated. The skin was removed from hind limbs and the left limb was sham 
treated while the right limb was treated with NT-plasma (n=3). B) Contralateral fore limb grading result at 
120 hours comparing sham and NT-plasma treatment of E18 autopod (n = 3) shows that in 33% of NT-
plasma treatment  promotes limb development and 67% have no impact at this stage. C) Contralateral hind 
limb grading result at 120 hours comparing skinless sham and Skinless NT-plasma treatment of E18 autopod 
(n = 3) shows that in 100% of the NT-plasma treatment of the skinless autopod promotes limb development 
(n=3). 
 
6.3. Discussion 
 
Limb autopod development was dramatically accelerated in response to NT-plasma 
treatment. Noticeable changes included enhanced development of digit length and 
definition of digit separation. These changes were coordinate with enhanced Wnt signaling 
in the distal apical epidermal ridge (AER) and presumptive joint regions. A single NT-
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plasma treatment continued to promote autopod development up to day 6 in culture, 
seemingly overcoming the negative culture environment normally observed in vitro. This 
was confirmed by the up-regulation of chondrogenic transcripts, determined by qPCR. 
Mechanistically, NT-plasma increased the number of ROS positive cells in the dorsal 
epithelium, mesenchyme and the distal tip of each phalange behind the AER, determined 
using dihydrorhodamine. The importance of ROS production/signaling during 
development was further demonstrated by the almost complete stunting of digital 
outgrowth when anti-oxidants were applied.  
While very little has been reported on the direct contribution of ROS in autopod 
developmental examples of how ROS affects differentiation and development do exist. In 
vivo, stem cells and adult MSCs have been reported to exist in a quiescent, glycolytic state 
with immature mitochondria [297]. Disruption of this environment by vascularization, 
growth factor binding, increased mitochondrial biogenesis or external stresses induces 
elevations in ROS levels leading to the induction of differentiation [298]. In addition, the 
requirement of ROS in the analogous process of regeneration was recently elucidated after 
tadpole tail amputation using fluorescent monitoring of H2O2 [299]. Additionally, 
regeneration in the non-mammalian systems, of both the axyotl salamander and Xenopus 
frog limbs, report the most upregulated protein day 1 after amputation is neuronal NOS 
(nNOS or NOS1) [300] A similar result, to what we observed at Day 1 post NT-plasma 
treatment, when endothelial NOS (eNOS or NOS3) expression was increased 2-fold above 
control in the mouse autopod. Nitric oxide is known to trigger enhanced induction of 
vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and 
during cutaneous wound repair [301, 302]. As stated above, increases in angiogenesis are 
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known to enhance differentiation and undoubtedly play a role in enhancing autopod growth 
and development. 
 However, the fact that NT-plasma treatment showed some growth effect 
even in the presence of antioxidants indicates ROS production may not be the sole 
mechanism driving enhanced autopod growth. A second possible reason NT-plasma 
enhanced autopod growth was its inhibition of epithelial overgrowth. Epithelial 
overgrowth is commonly observed in organ culture systems where direct contact with the 
nutrient rich media favors cells on the outer layers of the tissue [303, 304]. In limb 
regeneration a thickening of the epidermis has been shown to inhibit signaling to the 
blastema halting the regeneration process [305-307]. The observed decrease in epithelial 
thickening and increased limb growth after NT-plasma treatment supports this mechanism. 
Furthermore, when the skin of the autopod was removed, limb showed higher elongation 
and development confirming those findings. One explanation for our findings is the 
presence and distribution of H2O2 positive cells throughout the culture period which 
indicates the NT-plasma treatment has altered signaling and development within the 
epithelium. NT-plasma also affects the cartridge directly as indicated by the promotion of 
growth and elongation of the skinless autopod. 
The results of this study show that NT-plasma technology selectively initiated and 
amplified ROS intracellular signaling to enhance differentiation of progenitor cells in the 
developing autopod. Parallels between development and regeneration, suggest the potential 
use of NT-plasma could extend to clinical applications for enhanced fracture healing, 
skeletal trauma repair, and bone fusion.   
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 Mechanisms of Non-Thermal plasma Effect on Limb Autopod 
Elongation 
 
7.1. Introduction  
As seen in the previous chapters, NT-plasma enhanced limb bud survival, growth 
and elongation through increased production of intracellular ROS and Wnt signaling, 
which led to up-regulation of chondrogenic markers. Additionally, the production of 
intracellular ROS after direct contact of NT-plasma with biological tissue has been 
associated with changes in mitochondrial membrane potential and calcium fluxes. To 
further investigate the interplay between ROS and calcium, this chapter evaluated the 
contribution of intra- and extra-cellular to NT-plasma enhancement of limb development. 
The ROS and RNS produced by NT-plasma in combination with local and global 
electric fields have the potential to affect intracellular calcium concentrations [308-310].  
Three main mechanisms by which changes in intracellular calcium occur are 
through: 1) the activity of voltage-gated calcium channels, 2) increased permeability of the 
plasma membrane, such as nanoporation and 3) the release of the intracellular calcium 
stores. While the exact mechanistic connection between changes in calcium and 
downstream events in development are far from understood, calcium is a ubiquitous and 
versatile signaling molecule that participates in a wide range of processes from fertilization 
to organ formation [156, 311]. During development, tissues organize by a precise 
spatiotemporal modification of cell movements and cell shape changes, and calcium might 
play role in the coordination of these processes [155, 312]. 
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In the case of embryo hindlimb development, members of the Wnt-5A class stimulate 
the release of intracellular Ca2+ in a G-protein-dependent, but β-catenin-independent, 
manner [199]. The release of intracellular Ca2+ involves inositol(1,4,5)P3 receptors, and 
leads to the activation of two Ca2+-sensitive enzymes, Ca2+/calmodulin-dependent protein 
kinase II [313] and protein kinase C [314]. This ‘non-canonical’ Wnt pathway is known as 
the Wnt/Ca2+ pathway [199]. The possibility that NT-plasma is enhancing limb bud 
survival, growth and elongation by regulating changes in intracellular Ca2+ is intriguing. 
Herein, it is shown that Ca2+ is required for NT-plasma to promote limb bud elongation, 
but not survival. 
 
7.2. Materials and methods 
 Inhibitors of Cellular Calcium Flow 
Thapsigargin -  IP3-independent intracellular calcium releaser (Sigma Aldrich, 
MO) with working concentration 130nM was added to the cells 45min before plasma 
treatment and kept for 1h after treatment. Nefedipine - L-type Ca2+ channel blocker  
(Calbiochem), U73122 –Phospho Lipase C inhibitor, Nefiracetam - L/N-type calcium 
channels openneer (Tocris bioscience), with working concentration of 100mM, 1mM and 
1mM respectively were added to the cells 2h before NT-plasma treatment and kept for 1h 
after treatment. 
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 Fluorescent labeling of Calcium  
X-rhod-1, indicator of calcium (Invitrogen, NY). Working concentration of 2 μM 
prepared in PBS without calcium or magnesium, used with incubation time of 60min at 
370C after treatment. Cells were washed with PBS prior to NT-plasma treatment and placed 
in DMEM without phenol red and serum, and Fluorescence intensity was measured 1h after 
treatment using flow cytometry (MACS Quant VYB, Miltenyi Biotech, Sacramento, CA). 
 In vitro Limb Autopod Culture and Treatments 
Limb autopods were explanted from embryos of gestational ages E12.5 and 
cultured for up to 6 days in Dulbecco's Modified Eagle's Medium (DMEM; Cellgro, 
ThermoFisher Scientific, USA) or BGJb medium (Gibco, Life Science Technologies, 
USA) with 2% Fetal Bovine Serum (FBS) (Invitrogen, Life Science Technologies, USA), 
and supplemented with 100 units/ml penicillin,100 µg/ml streptomycin (Cellgro, 
ThermoFisher Scientific, USA) using the method previously described [282]. The limbs 
were placed on a naylon membrane in 12 well plates. 220 µl of medium (DMEM or BGJB) 
was added to each limb. Approximately 1 hour after isolation, NT-plasma or sham plasma 
treatment was applied to the left or right limb autopod from the same animal. The following 
morning the culture medium was changed and 1% FBS was added. The medium (DMEM 
with 2% FBS) was changed daily thereafter for the 4-6 days of culture.  
 Calcium Chelation 
Ethylenediaminetetraacetic acid, widely abbreviated as EDTA is an 
aminopolycarboxylic acid and a colourless, water-soluble solid. Its usefulness arises 
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because of its role as a hexadentate ("six-toothed") ligand and chelating agent, i.e. its ability 
to "sequester" metal ions such as Ca2+ and Fe3+. After being bound by EDTA, metal ions 
remain in solution but exhibit diminished reactivity.  
 Cell Culture 
The cells were maintained in culture using the method described previously [315]. 
C3H10T1/2 (ATCC (CCL-226), Manassas, VA) cells were cultured in DMEM with 5% 
FBS and 5% fetal calf serum (FCS) (Invitrogen, Life Science Technologies, USA) with 
1% penicillin/streptomycin and incubated in 5% CO2 at 37oC. 
 Fluorescent Indicators 
X-rhod-1, an indicator of intracellular calcium (Invitrogen, NY) was prepared at a 
working concentration of 2 μM in PBS without calcium or magnesium was incubated with 
the cells for 60 min. at 370C after NT-plasma treatment. Cells were washed with PBS prior 
to NT-plasma treatment and placed in DMEM without phenol red and serum, and 
fluorescence intensity was measured 1h after treatment using flow cytometry (MACS 
Quant VYB, Miltenyi Biotech, Sacramento, CA). The cells were exited at wavelength of 
561nm and fluorescent emission was recorded between 586 nm with band width of 15nm.  
 Dihydrorhodamine 123 [DHR] is ab indicator of, H2O2 a (Invitrogen, NY). 
Working concentration of 2.5 μM was used with incubation time of 30min after treatment. 
Cells were washed with PBS and then placed in phenol free DMEM prior to fluorescence 
intensity reading. Fluorescence intensity was measured using flow cytometry (MACS 
Quant VYB, Miltenyi Biotech, Sacramento, CA). 
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 Calcium Indicators 
Nefedipine - L-type Ca2+ channel blocker  (Calbiochem) and U73122 –Phospho 
Lipase C inhibitor  with working concentrations of 100mM, 1mM respectively were added 
to the cells 2h before NT-plasma treatment and kept for 1h after treatment. 
 
7.3. Results 
  Limb Autopod Survival is Decreased by Extracellular Ions in Culturing 
Media 
To determine if ions in the culture media play a role NT-plasma’s ability to enhance 
survival, growth and elongation of limb autopods, EDTA was added to the DMEM culture 
media for 5 days during autopod growth.   EDTA is a known chelater of the metal ions 
Ca2+ and Mg2+ [316]. Mouse E12.5 autopod survival was significantly increased when 
cultured in DMEM with EDTA (86%) compared to DMEM (75%, p=0.00085, Figure 64), 
but limb growth and elongation were not significantly affected. NT-plasma treatment of 
autopods in DMEM with EDTA showed a slight improvement of limb survival (NT-plasma 
92%, sham 86%), but not significantly above sham treatment (p= 0.7034, Figure 65). 
Moreover, no effect on elongation or growth was observed following NT-plasma treatment. 
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Figure 64: E12.5 Limb grading results at Day 5 hours comparing sham cultured in DMEM (n=73) and sham 
cultured in DMEM supplemented with EDTA (n=9).  
 
 
Figure 65:  E12.5 Limb grading results at Day 5 comparing sham cultured in DMEM + EDTA (n=9) and NT-
plasma treatment in DMEM + EDTA (n=12) showing that NT-plasma promoted limb survival by 7% 
compared to EDTA sham but had no effect on growth or elongation.  
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To evaluate the direct role of Ca2+ autopods were cultured in BGJb calcium free 
media. BGJb media was designed specifically to culture skeletal tissues to optimally 
promote the growth of cartilage and bone. (ref)  E12.5 mouse autopods maintained in 
culture in BGJb media for 5 days were graded and compared to limbs grown in DMEM 
(Figure 66). Limbs grown in BGJb media (n=14) showed increased limb survival (8%) 
compared to limbs in DMEM media (n=73; 25% stunted; p<0.00001), but there was no 
difference in elongation (4% DMEM sham, 7% BGJb sham). NT-plasma treatment of 
autopods in BGJb compared to sham (Figure 67) showed no significant difference in 
survival or elongation; but it did promote a significant increase in overall limb growth 
(28%, p=0.016). Both DMEM with EDTA and BGJb media without Ca2+, enhanced autpod 
survival, blocked limb elongation, A similar survival rate was observed when autopods in 
DMEM with and without extracellular Ca2+ were treated with NT-plasma, but limb 
elongation did not occur without Ca2+(p=0.033) (Figure 68). 
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Figure 66: Limb grading results at Day 5 comparing sham treatment in BGJB (n=14) and sham treatment in 
DMEM (n=73). BGJb medium promotes limb survival (p<0.00001) but not elongation 
 
 
Figure 67: Limb grading results at Day 5 comparing sham (n=14)  and NT-plasma treatment (n=26) of 
autopod cultured in BGJb. NT-plasma has no effect on limbs survival or elongation compare to BGJb sham 
but promotes overall autopod growth(p=0.016) . 
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Figure 68: Limb grading results at 120 hours comparing sham treatment in BGJb (n=14) and NT-plasma 
(n=61) treatment in DMEM. Both NT-plasma and BGJb shows  better survival (NT plasma 92%, BGJb sham 
93%)  compared with DMEM sham (A, 75%), and shows 19% increase in elongation in NT-plasma treatment 
in DMEM medium compared to BGJb sham (p=0.033). 
 
  Increased Intracellular Calcium Alone doesn’t Enhance Limb Autopod 
Elongation 
Intracellular Ca2+release ([Ca2+]i) in the presence or absence of extracellular 
calcium  was investigated to determine the involvement of calcium dynamics in the 
enhancement of autopod survival and the lack of limb elongation (Figure 65 and Figure 
67). Thapsigargin, a chemical which rapidly increases the intracellular [Ca2+]i by releasing 
calcium from the sarcoplasmic and endoplasmic reticula was added to the media. In 
addition to releasing stored Ca2+, thapsigargin activates plasma membrane calcium 
channels and calcium is internalized from the media ([Ca2+]e). 
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Figure 69: A) Limb grading results at Day 5 comparing sham, NT-plasma (n=26) and Thapsigargin (n=27) 
treatments of autopod cultured in BGJb. Neither NT-plasma nor Thapsigargin promotes autopod elongation 
compared to sham control. 
 
Thapsigargen was added to both calcium free BGJb media and calcium containing 
DMEM media to investigate the synergy between [Ca2+]e and [Ca2+]i effects on limb 
elongation. Numerical grading results comparing sham, NT-plasma and thapsigargin 
treatment of E12.5 autopods cultured in BGJb medium are shown in Figure 69. In BGJb 
media, thapsigargin treatment significantly decreased limb survival (22%, p=0.05) 
compared to sham 7%, and NT-plasma 11%, no significant effects on elongation.  When 
the same experiment was performed in DMEM, thapsigargin treatment again significantly 
decreased limb survival (20%, p=0.05) compared to NT-plasma 8%, but not sham 24% 
(Figure 70). Furthermore, limb elongation was not enhanced in either sham or thapsigargin 
containing media, as compared to the significant increase by NT-plasma treatment (5 vs 
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27%). Therefore, as thapsigargin treatment in both Ca2+ free or Ca2+ rich media failed to 
enhance limb elongation, an increase in [Ca2+]i alone is not sufficient to induce elongation.  
 
 
Figure 70: Limb grading results at Day 5 comparing sham (n=73),  NT-plasma (n=61) and thapsigargin 
(n=20) treatments of autopod cultured in DMEM. While NT-plasma treatment promotes elongation 
compared to sham treatment, thapsigargin doesn’t. 
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 Increased Intracellular Calcium Combined with NT-plasma Treatment 
is Required for Enhanced Limb Autopod Elongation 
 
 
Figure 71: Limb grading results at Day 5 comparing NT-plasma (n=26) and thapsigargin with NT-plasma 
treatment (n=11) of autopod cultured in BGJb. NT-plasma treatment following thapsigargin treatment 
significantly promoted autopod growth (p=0.005) and showed 36% elongation compared to 8% after NT-
plasma alone (p=0.035). The survival after NT-plasma plus Thapsigargin treatment was increased by 11% 
compared to NT-plasma treatment. 
 
To investigate if increases in [Ca2+]i are synergistic with NT-plasma treatment, 
autopods were incubated in BGJb or DMEM with and without thapsigargin (Figure 71, 
Figure 72). In BGJb media with thapsigargin, NT-plasma treatment enhanced survival and 
elongation. 100% of the NT-plasma and thapsigargin limbs showed growth with 36% 
elongation compared to only 8% when NT-plasma alone was used as a treatment (p=0.035, 
Figure 71). A similar enhancement of autopod survival (Figure 72) was observed in 
DMEM and thapsigargin after NT-plasma treatment (100% vs 89% p<0.0001). While 
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growth was not significantly affected under these conditions, the effect on elongation was 
comparable to BGJb with thapsigargin (p=0.2878). A summary table of the results from 
each of the experimental conditions is presented in Table 5. Limb elongation only occurred 
when either intracellular or extracellular calcium was present in combination with NT-
plasma treatment. In calcium free media (BGJb), only thapsigargin coupled with NT-
plasma treatment gave rise to elongation of the limb autopod. Therefore, whether the 
increase in intracellular calcium came from the external media or from thapsigargin-
mediated release of intracellular stores, either results in autopod elongation. If limb 
autopod survival is used as an indicator of an optimal treatment, it appears that in the 
absence of NT-plasma extracellular calcium generally reduces overall autopod survival.  
 
 
Figure 72: Limb grading results at Day 5 comparing NT-plasma treatment (n=61) and Thapsigargin plus NT-
plasma treatment (n=12) of autopod cultured in DMEM. NT-plasma treatment following thapsigargin 
treatment significantly promoted autopod growth (p<0.0001) and survival (p<0.0001). Similar elongation 
was observed after NT-plasma treatment alone and NT-plasma treatment following Thapsigargin (p=0.2878). 
 
129 
 
Table 5: Summary of limb autopod elongation depending on treatment conditions 
 
 
 Mechanisms of Intracellular Calcium Increase by NT-Plasma 
To ascertain whether treatment with NT-plasma increases intracellular calcium 
levels, the X-rhod-1 fluorescent indicator was added to the media after the cells were 
treated with NT-plasma.  Fluorescent levels were measured at 1h after NT-plasma 
treatment relative to DMEM control. NT-plasma treatment significantly increased [Ca2+]i 
compared to sham treatment (694%) (Figure 73).  To determine if the increase in [Ca2+]i 
was due to the release of calcium from intracellular stores effect the cells were treated with 
  Treatment [Ca2+]e [Ca2+]i ROS Elongation
Sham Yes No No No
NT-Plasma Yes No Yes Yes
Thapsigargin Yes Yes No No
Thapsigargin + 
NT-Plasma
Yes Yes Yes Yes
Sham No No No No
Plasma No No Yes No
Thapsigargin No Yes No No
Thapsigargin + 
Plasma
No Yes Yes Yes
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thapsigargin and [Ca2+]i levels were measured with X-rhod-1 1h after either thapsigargin 
treatment or thapsigargin followed by NT-plasma treatment.  Thapsigargin treatment alone 
elevated intracellular calcium levels 148% compared to control while NT-plasma treatment 
with thapsigargen further increased [Ca2+]i relative to control (274%) (Figure 73). 
However, neither treatment matched the increase displayed by NT-plasma alone. 
 
 
Figure 73: Intracellular Calcium detected using X-rhod-1 fluorescent indicator. Results compare NT-plasma 
and sham treatment in DMEM media compared to sham and NT-plasma treatment after the addition of 
thapsigargin to the media. NT-plasma, thapsigargin and their combination elevates intracellular calcium 
compared to DMEM sham. NT-plasma is the most effective among them. 
 
  
131 
 
To reinforce the validity of these results, the phosphor-lipase C (PLC) inhibitor 
U73122 was also used. PLC activation is known to cause the release of intracellular 
calcium stores, therefore blocking PLC indirectly blocks release of calcium from the stores. 
Figure 74 reveals that NT-plasma treatment with U73122 partially suppressed the [Ca2+]i 
increase compared to NT-plasma alone (468% compared to 694%). Consequently, this 
indicates that NT-plasma treatment may cause release of intracellular calcium stores, but 
this mechanism does not account completely for the large increase of [Ca2+]i observed after 
NT-plasma treatment.  
 
 
Figure 74: Intracellular Calcium detected using X-rhod-1 fluorescent indicator. Results compare NT-plasma 
and sham treatment in DMEM media to sham and NT-plasma treatment of cells pre-treated with U73122. 
U73122 is Phospho Lipase C inhibitor. NT-plasma treatment following U73122 increase the [Ca2+]i 
compared to sham treatment (469%) but the [Ca2+]i level remained lower than NT-plasma alone (694%). 
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Figure 75: Intracellular Calcium detected using X-rhod-1 fluorescent indicator. Results comparing NT-
plasma and sham treatment in DMEM media to sham and NT-plasma treatment after the addition of 
nifedipine, L-type Ca2+ channel blocker, to the media. Nifedipine completely blocked intracellular Ca2+ 
increase after NT-plasma treatment. 
 
As pulsed electric fields have been shown to activate voltage sensitive calcium 
channels, it is plausible that NT-plasma treatment could also activate them and increase 
intracellular calcium levels by this mechanism.  To investigate this, cells were treated with 
Nifedipine, an L-type Ca2+ channel blocker, for 1 h before NT-plasma treatment.   
Comparisons of [Ca2+]i of NT-plasma to NT -plasma treatment after pre-treatment of the 
cells with Nifedipine in DMEM media show a complete blockage of the increased [Ca2+]i 
(Figure 75). Nifedipine treatment alone showed no change in the intracellular levels 
compared to sham treatment; all values were normalized to control DMEM. This result 
shows that the increases in [Ca2+]i after NT-plasma treatment is due to calcium influx 
through the L-type Ca2+ channels on the plasma-membrane. The release of intracellular 
calcium stores may occur as a consequence of this influx, accounting for the partial 
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decrease in [Ca2+]i levels after treatment with the PLC inhibitor U73122 in combination 
with NT-plasma treatment. 
 
  Intracellular Calcium Correlation to Intracellular H2O2 Production 
Following NT-Plasma 
To investigate the relationship between [Ca2+]i and ROS, intracellular hydrogen 
peroxide, [H2O2]i, levels were assessed using fluorescent indicator DHR. Figure 76 
displays the [H2O2]i levels relative to sham control and NT-Plasma treatment. NT-plasma 
treatment amplifies the [H2O2]i levels to 272% compared to sham treatment. Thapsigargen 
sham treatment enhances the [H2O2]i levels by 25% above sham control levels and the 
combination of thapsigargin and NT-plasma result in [H2O2]i levels of similar to NT-
plasma alone. The difference in [H2O2]i levels between NT-plasma and NT-plasma plus 
thapsigargin is statistically insignificant. 
 
134 
 
 
Figure 76: Comparison of Intracellular H2O2 of NT-plasma treatment and sham treatment in DMEM medium 
alone and DMEM with Thapsigargin. In both cases NT-plasma significantly increased intracellular calcium 
compared to DMEM sham (p<0.0001). Thapsigargin alone raised intracellular calcium levels above DMEM 
sham (p=0.0001) but stayed below calcium levels compared to NT plasma treatment (p=0.003). 
 
 
Figure 77: Comparison of Intracellular H2O2 of NT-plasma treatment and sham treatment in DMEM medium 
alone and DMEM with U73122 (Phospho Lipase C inhibitor). Phospho Lipase C inhibitor sham significantly 
lowered H2O2 levels compared to DMEM sham (0.0003) and NT-plasma in DMEM (p=0.005). 
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Figure 77 compares the [H2O2]i levels of sham control versus NT-plasma treatment 
in media pre-treated with U73122. U73122 partially blocks the [H2O2]i increase after 
plasma treatment (157%) compared to NT-plasma treatment (272%). 
 
 
Figure 78: Comparison of Intracellular H2O2 of NT-plasma treatment and sham treatment in DMEM medium 
alone and DMEM with Nifedipine (L-type Ca2+ channel blocker). Nifedipine had no effect on intracellular 
H2O2 after plasma treatment compare to DMEM plasma, but Nifedipine sham increase the H2O2 levels 
above DMEM sham (p<0.0001). 
 
 NT-plasma effects on cellular permeability  
To determine whether NT-plasma increases cell membrane permeability without 
cell death, cell death and permeability were assessed with propidium iodide (PI) and sytox 
fluorescent indicators cells after NT-plasma treatment.  Cell death increases the 
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permeability of the cell membrane and as the Sytox dye has a much smaller molecular size 
compared to propidium iodide it has been used to determine if transient permeability 
occurs, such as after pEF treatment[310, 317]. To test this, cells were treated with NT-
plasma and then incubated with both dyes. If a population is sytox positive but not PI 
positive, it indicates a transient permeabilization, if both sytox and PI positive cell death is 
indicated. As can be seen from graphs generated from flow cytometry analysis of the 
treated cells (Figure 79), the cells are either PI and sytox negative or PI and sytox positive, 
indicating that all dead cells are permeable, but live cell are not at1h after NT-plasma 
treatment. 
 
 
Figure 79: Results of fluorescent intensity comparison between cells labeled with Propidium iodide and sytox 
show that cells PI positive are also Sytox positive. This indicates that only dead cells are permeable. 
 
The treatment conditions explored in this chapter and their result is summarize in 
Table 6. 
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Table 6: Summary of intracellular calcium and hydrogen peroxide levels compared to sham DMEM after 
sham and NT-plasma and various treatments discussed in this chapter. 
 
 
  
Media Treatment Intracellular 
Calcium
Intracellular 
H2O2
1 DMEM Sham No No
2 DMEM Plasma High High
3 Thapsigargin Sham Low Low
4 Thapsigargin Plasma Low High
5 U73122 Sham No No
6 U73122 Plasma High Low
7 Nifedipine Sham No High
8 Nifedipine Plasma No High
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7.4. Discussion 
The hypothesis was that NT-plasma induced autopod development requires an 
increase in intracellular calcium. Findings from this study directly identify calcium as a 
prerequisite for NT-plasma induced limb elongation. However, chelating extracellular 
calcium from the media or use of BGJb, a media with no calcium, significantly improved 
in vitro autopod survival. In contrast, NT-plasma induced limb elongation was inhibited by 
the lack of extracellular calcium. The addition of thapsigargin to BGJb medium increased 
intracellular calcium but not limb elongation, unless combined with NT-plasma treatment. 
When extracellular calcium was present, limb elongation occurred in response to NT-
plasma treatment regardless of thapsigargin pretreatment. Taken together these results 
indicate that limb elongation, but not survival, requires both NT-plasma treatment and 
calcium. Additionally, the increase in intracellular calcium in response to NT-plasma was 
due to an influx of extracellular calcium, as the voltage-gated calcium channel inhibitor 
nifedipine blocked this response.  
A good candidate for causing limb elongation is the ROS generation by NT-plasma 
and the activation of ROS and calcium signaling cascades within the limb.  Many 
references in the literature extoll the multiple interactions between intracellular calcium 
and ROS signaling to control cellular function[160, 163].  Specifically, Ca2+ transients are 
thought to function at a later stage in skeletal muscle development. De Deyne [318] 
suggested a role for extracellular Ca2+ in sarcomere assembly and maintenance when he 
showed that the formation of the sarcomeres in developing myotubes that were isolated 
from the hindlimbs of rat neonates could be inhibited by EGTA, which chelates 
extracellular Ca2+, and by L-type Ca2+-channel inhibitors, which block the passage of 
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extracellular Ca2+ into cells. In addition, there is evidence that members of the cadherin 
family of Ca2+-dependent cell-adhesion molecules have a role in the development of the 
myotome and the formation of the skeletal muscle in both chick and mouse 100,101. 
FIGURE 5 illustrates a series of localized Ca2+ transients down the trunk musculature of 
a zebrafish embryo at18 hpf. Once again, owing to the near simultaneous appearance of 
the signals over many cell diameters, we propose that they are generated by a mechanism 
similar to that illustrated in FIG. 6d. 
Finally, as pulsed electric fields (pEF) are generated by NT-plasma and are known 
to increase cell membrane permeability and the influx of calcium [ref]. However, our 
supplementary data show this is not the case and the complete blockage of increased 
intracellular calcium by nifedipine confirms this. NT-plasma significantly elevates both 
intracellular calcium and H2O2 levels in cells after NT-plasma treatment. Mechanistically, 
it was found that NT plasma opens voltage sensitive L-type Ca2+ channels and releases 
calcium from intracellular calcium stores. It was verified that 1 hour post-plasma treatment 
there is no increase in transient cell permeability in live cells. It doesn’t rule out the 
possibility that plasma caused very rapid cell permeability for a short period of time before 
the dyes were added and the cell membrane recovers before the addition of the dye, one 
hour after plasma. 
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 Dielectric Barrier Discharge Prameters Effect on Limb Development 
8.1. Results 
  Tissue damage is caused by filaments from the 5 mm electrode 
As described in Chapter 6: when limb autopods were stained with DHR stain to 
reveal intracellular H2O2, damage extending up to 1 mm was observed in the limb epithelia 
after NT-plasma treatment.  Figure 80 images display DHR staining of the limb autopod at 
Day 1 and Day 6 after plasma. The day one image shows a very bright green staining 
intensity at the damage location (white arrow). By day 6 darker circular indentations appear 
at the spot where filament damage occurred. This area is no longer DHR positive and has 
undergone some healing, a process well documented in limb epithelia. Despite the damage, 
NT-plasma treatment was still able to promote limb survival, growth and elongation in 
76% of the limbs, compared to the sham treatment (Figure 51).  
 
 
Figure 80: Skin Damage is observed in the autopod after NT-plasma treatment, as discovered with fluorescent 
H2O2 indicator. 
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To determine the extent of cell death at the NT-plasma treatment site were injury 
occurred, NT-plasma treated autopods were stained with both DHR and propidium iodide 
(PI- dead cells). Positively stained (red) PI positive cells indicating death was primarily 
localized to the area immediately surrounding the NT-plasma treatment site (Figure 81, co-
localized H2O2 (green) and PI (red) positive cells). Outside this region very few H2O2 
positive cells are co-localized with PI, indicating the H2O2 positive cells are not necessarily 
dead cells. Other PI positive cells are also visualized that are not H2O2 positive.  
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Figure 81: To determine the effect of NT-plasma and ROS production on cell viability, the limb autopods 
were stained with both dihydrorhodamine (DHR), to detect H2O2 and propidium iodide (PI), an indicator of 
cell death. The untreated controls (A) and NT-plasma treated limb (B) images for each dye, the overlay and 
the transmitted light image are shown. A high magnification inset of the NT-plasma treated region and the 
surrounding area show epithelial cell death primarily localized to the immediate area of treatment (C and D).  
 
  Optimization of electrodes to prevent fixed filament pattern and still 
enhance limb growth 
In order to retain the positive effect of NT-plasma and achieve less damage to the 
limb autopod two strategies were employed to decrease filamentation. First, the power of 
NT-plasma was reduced by changing the treatment frequency from 1 kHz to 50 Hz. Figure 
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82 demonstrates that both NT-plasma treatments at both of these frequencies still resulted 
in damage up to 1mm in depth to the epithelial tissue.  
 
 
Figure 82: Images of dihydrorhodamine staining comparing 50 Hz and 1kHz NT-plasma treatment. Both 
treatments were performed for 10s with round tip electrode. 
 
To decrease discharge power density a new larger electrode was built. The 5mm 
electrode used to this point was constructed with a round tip.  This caused the electric field 
at tip of the electrode to be very high, increasing the potential for focusing the energy to 
cause larger filaments and streamer formation at the electrode tip. To avoid this, two new 
electrodes were designed to be flat and much larger. One electrode had inner diameter of 
1.03 cm and outer diameter of 1.25 cm which allowed it to fit into the 24-well cell culture 
plate. While the second larger electrode had inner diameter of 2.3 cm and an outer diameter 
of 3.8 cm and fit into the 6-well cell culture plate. Figure 83 compares side view images of 
the discharge ignited with the three different electrodes. As can be observed from these 
images, the round electrode has clustering of filaments and/or streamers at its tip and more 
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diffused glow slightly wider the electrode width. The new, 24-and 6-well electrodes exhibit 
a more diffuse uniform pattern of discharge; although multiple filaments are observed 
along the width of the electrode.   
 
 
Figure 83: Front (top) and Side (bottom) view of the discharge with a) 96-well spherical electrode, b) 24-
well flat electrode c) 6-well flat electrode. ISO 1600, f=1/4, shutter time - 0.5 s, frequency – 50 Hz, electrode 
distance -2mm. Images not to scale. 
 
Figure 84 compares DHR staining of limb epidermis layer as after NT-plasma 
treatment performed with 24 well electrode at 50 Hz and 1 kHz for 10s. 1 kHz treatment 
shows more H2O2 signaling and more damage as compared to 50 Hz treatment. Comparing 
Figure 82 and Figure 84 reveals that 24-well flat electrode shows less severe damage to the 
epidermis layer.    
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Figure 84: Images of dihydrorhodamine staining comparing 50 Hz and 1kHz NT-plasma treatment. Both 
treatments were performed for 10s with 24 well flat electrode. 
 
Figure 85 compares DHR staining of the epidermis layer after NT-plasma treatment 
with 6-well electrode. It can be observed that 50 Hz treatment with 6-well-flat electrode 
has no visible damage to the skin layer and 1 kHz treatment exhibits minor cell damage. 
Comparing Figure 82 with Figure 84 and Figure 85 confirms that flat geometry electrodes 
under the same treatment conditions (frequency, time, distance from the sample) causes 
less damage to the epithelium compared to a rounded electrode. Moreover, larger size 
electrodes exhibits less damage under the same treatment conditions compared to smaller 
size electrode. In additions, the damage after NT-plasma treatment with 6-well electrode 
at 1 kHz is less severe than NT-plasma treatment with 24-well electrode at 50 kHz. Since 
the area ratio of 6-well electrode to 24-well electrode is 5 but the plasma energy ration 
between 1 kHz and 50 Hz is 20, larger plasma dose was not the main reason for stronger 
damage of the epidermis layer. 
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Figure 85: Images of dihydrorhodamine staining comparing 50 Hz and 1 kHz NT-plasma treatment. Both 
treatments were performed for 10 s with 6-well flat electrode. 
 
 Optimizing DBD Electrode to maximize autopod survival, growth and 
elongation 
To establish the effect of electrode geometry on limb growth, E14.5 autopod limbs 
were treated with the three electrodes described previously – the round 5 mm electrode, the 
flat 24-well and the 6-well electrodes at 1 kHz frequency for 10s. Figure 86 illustrates the 
effect of NT-plasma treatment on bilateral limbs and indicates treatment with either the 24-
well or 6-well flat electrodes at 1 kHz enhances the growth of a larger percentage of 
autopods, as compared to the round electrode.  Additionally, the larger the electrode size, 
the better the autopod growth results.  Figure 87 shows numerical grading results of sham 
and NT-plasma treatments performed with each electrode. While all NT-plasma treatments 
improved autopod elongation, only the 6-well electrode promotes a 100% survival, a 
significant improvement over sham and the other NT-plasma treatments (P<0.0001). This 
data suggest that minimizing cellular damage at the epithelium improves limb survival. 
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Figure 86: A) Contralateral E14.5 limb grading comparing sham and NT-plasma treatments for round, 24-
well and 6-well electrodes. All plasma treatments were performed with frequency of 1 kHz and treatment 
time of 10s. From left: round electrode (n=30, p=0.029), 24 well flat electrode (n=7, p=0.031), 6 well flat 
electrode (n=19, p=0.00017). B) Side view of the  
 
 
Figure 87: Numerical grading result comparing sham (n=135) and NT-plasma treatments with 96-well 
(n=39), 24-well (n=20) and 6-well (n=32) electrodes. All plasma treatments were performing with frequency 
of 1 kHz and treatment time of 10 s.  
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Since Figure 84 and Figure 85 show less damage with lower frequency, limb 
growth was assessed for NT-plasma treatment at 50 Hz with the 24 and 6 well flat 
electrodes. Figure 88 compares sham and NT-plasma treatment at 50 Hz for both 
electrodes. Results indicate that lowering the frequency to 50 Hz with the 24-well electrode 
significantly reduced NT-plasma efficiency (55%). When the 1 kHz frequency is used, NT-
plasma had a greater effectiveness of 86%.  Differences between the lower and higher 
frequency treatments using the 6-well electrodes were smaller, 82% at 50 Hz and 90% at 
1 kHz. Figure 89 displays numerical grading analysis comparing sham treatment and NT-
plasma treatments with 6 and 24-well electrodes at 50Hz. 6-well electrode treatment 
resulted in highest percent of limb elongation compare to sham (65%, p<0.00001) 
treatment.  Both 24-well and 6-well treatments at 50 Hz significantly improved limb 
survival compare to sham treatment (p=0.038 and p=0.008, respectively). Comparing 6-
well electrode treatments at 50 and 1000 Hz reveals that dose treatments are similar on all 
parameters: survival, elongation and growth. This result suggest that there is a wide range 
of NT-plasma treatment doses which enhances limb elongation and that smaller electrodes 
exhibit greater streamer formation and tissue damage. 
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Figure 88: Contralateral E14.5 limb grading comparing sham and NT-plasma treatments. All plasma 
treatments were performing with frequency of 50 Hz and treatment time of 10s. Left: 24-well flat electrode 
(n=11, p=0.351), 6-well flat electrode (n=11, p=0.013). 
 
 
Figure 89: Numerical grading result comparing sham (n=135) and NT-plasma treatments with 24-well (n=12) 
and 6-well (n=12) electrodes. All plasma treatments were performing with frequency of 1 kHz and treatment 
time of 10s. 6-well electrode significantly promoted elongation compared to sham and 24-well electrode  
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 Multiple treatments 
To test if NT-plasma application repetition will enhanced further limb growth and 
elongation, E12.5 autopod were treated three times at 1000 Hz for 10s. The treatments were 
performed on Day 0, Day 1 and  Day 2.  The NT-plasma treatment was performed with the 
6-well electrode. Figure 90 presents that multiple application of NT-plasma had 100% 
success rate compared to the sham control (p=0.0003, n=14). 
 
 
Figure 90: A) Consecutive images of day 1 to day 6 of limbs after three NT-plasma treatments of 10s each 
applied on day 0, day 1, and day 2. B) NT-plasma threated limbs enhanced digit development in an E12.5 
autopod compared to its contralateral sham control for a single NT-plasma treatment (1 kHz, 6-well 
electrode). C) NT-plasma threated limbs enhanced digit development in an E12.5 autopod compared to its 
contralateral sham control for a three consecutive NT-plasma treatments (1 kHz, 6-well electrode). 
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8.2. Discussion 
NT-plasma treatment stimulates autopod survival, growth and elongation. 
Nevertheless, when using the 5mm electrode significant tissue damage occurs on the 
epithelial layer. In order to minimize tissue damage, NT-plasma dose can be optimized by 
changing discharge frequency or treatment time.  In the experimental results presented, 
treatment time was fix to 10s to minimize tissue drying, as very little medium is present 
during the treatment. Changing the frequency of the round electrode did not resolve the 
issue of tissue damage of the epithelia. To effectively minimize electrode damage, 
electrode geometry was changed from round to planer. An electrode with a planar geometry 
showed less damage with smaller less deep pitting of the epithelium layer as compared to 
the round electrode. Farther increasing electrode surface area further reduced the damage 
to the epithelium at 1000 Hz frequency and eliminated the visual damage at 50 Hz. 
Effectiveness of the new electrode geometries on limb growth, elongation and survival was 
tested and it was discovered that the electrode geometry that resulted in the least damage 
to epithelium tissue also improved limb survival, growth and elongation greatest extent. 
The 6 well electrode was found to be the most effective electrode under both frequencies, 
with more than 80% and 90% treatment efficiencies at 50 and 1000 Hz respectively.  
As the electrode size and geometry was changed this resulted in changes in plasma 
characteristics, including power density and discharge power. Changes in frequency affects 
discharge power, while changing discharge geometry and size effects filament patterning 
within the discharge. Interestingly, discharge frequency effects filament pattern as well.  
Factors effecting discharge characteristics, filament pattern and discharge power were 
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measured under different plasma conditions and the results are presented in the next 
chapter. 
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 Filament Pattern Characteristics  
 
9.1. Introduction 
While sterilization of inanimate objects with non-thermal plasma (NT-Plasma) 
might be achieved by several methods, including wide range of NT-plasma doses, different 
discharges and electrode sizes, application of non-thermal plasma directly to living 
organisms, cells and tissue requires delicate tuning. In the previous chapters was described 
that NT-plasma can be successfully used for differentiating mesenchymal cells and 
promoting limb autopod development. Chapter 8: showed that limb autopod development 
was optimized by using flat geometry electrode compared to round edge electrode. It was 
shown that the large area flat electrode (6-well) was more efficient for limb autopod 
treatment and development compared to the small area flat electrode (24-well). This 
phenomena was not proportional to NT-plasma energy dose. Also shown in Chapter 8: that 
round edge electrode caused more damage to the limb epidermis compare with flat area 
electrode and that large area electrode showed less damage compared to the small area 
electrode regardless of treatment frequency and dose. Thus, it is hypothesized that flat area 
electrode has finer filaments compared to the round edge electrode in terms of filament 
size and strength. Therefore, discharge spatial distribution was studied under different 
discharge generation conditions.  In this chapter, Dielectric Barrier Discharge parameters 
will be explored and experimental results showing their significance for filament 
formation.  
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Parameters affecting NT-plasma dose include treatment time, frequency, voltage, 
current, pulse width, duty cycle, electrode size, discharge gap, discharge gas and electrode 
material. Does each of these parameters is of equal importance to biological activity?  To 
date, this question has not been answered. To explore scaling of DBD electrode size and 
correlate these changes with cell/tissue responses, discharge energy, filament distribution 
and was measured for three electrode sizes and various NT-plasma parameters: frequency, 
gap between electrodes, treatment time. 
 
9.2. Materials and Methods 
Discharge photographs were taken with Nikon D-70 camera at ISO 1600 and 
aperture of ¼. Maximum resolution was utilized to generate high quality images that were 
later used in image analysis software (Image-Pro Plus 7.0, Media Cybernetics, Rockville, 
MD) to provide insight into discharge mean intensity, organization, number of filaments, 
etc. Schematic representation of the experimental setup is shown in Figure 91. Dielectric 
Barrier Discharge was generated by applying alternating polarity pulsed voltage between 
the quartz-insulated high voltage electrode and the glass plate coated with indium tin oxide 
(ITO). The advantage of using the ITO plate is that it is electrically conductive and 
transparent, therefore the discharge can be observed through the electrode in the current 
direction. 
The ITO was grounded and the distance between the electrodes was set to 1-2 mm 
(Figure 91). Camera shutter time varied to capture 1-500 discharge pulses according to the 
discharge frequency. 
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Figure 91: A) Experimental setup for photographing discharge patterns. The setup includes digital camera; 
grounded glass plate coated with indium tin oxide (ITO) which is both transparent and electrically 
conductive; high voltage electrode, x-axis stage for control of the gap between high voltage electrode and 
ITO. B) Photograph of 24-well electrode obtained through ITO glass without NT-plasma discharge. C)  
Photograph of 24-well electrode obtained through ITO glass in the dark. Discharge conditions: voltage of 
20.2kV, frequency of 500Hz, 0.4s; photograph conditions: ISO 1600, f=1/4. 
 
9.3. Results 
To determine the contribution to of various discharge parameters on filament 
distribution and spatial uniformity, front and side view discharge images where taken 
through an indium tin oxide (ITO) glass. Figure 83 shows example of the front and side 
view images of the discharge with 96-well spherical electrode and 24-well and 6-well flat 
electrodes. The front view of the 24 and 6-well electrodes shows uniform discharge in the 
macroscopic scale. The side view of the figures of the same electrodes indicate that the 
discharge is not laterally homogeneous but filamentary instead in several regions even for 
the 24 and 6-well electrode. The 96-well spherical electrode front image shows a strong 
filament in the middle located at the tip of the electrode (side view) where the distance 
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between the 96-well electrode and the ITO glass is the shortest, and some glow on the side 
of the electrode.  
In order to quantify the filament patterns, we developed image analysis 
methodology. First, the images were converted to a black and white images and the image 
background was subtracted. Next, the images were calibrated to the corresponding 
electrode area to account for differences in camera location when the distance between 
electrodes was altered. Then, the filaments were divided into 5 classes based on their area.  
The determination of the classes range was arbitrary and used to compare between different 
treatments. Table 7 shows class colors and class range (the minimum and maximum size 
of filaments). For each class, the number of filaments, their area (in mm) and intensity were 
measured. Analysis example for 12-well electrode at 2mm distance between electrodes is 
shown in Figure 92. 
 
Table 7: The Filament pattern classification. The filament distribution was arbitrary divided into 5 classes 
based on filament size.  
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As expected, the images become brighter as shutter time left open for a longer time, 
as more light and more filaments are accumulates. Figure 92B shows the filament pattern 
based on the filament size. The colors match the class number reported in Table 7. As the 
time progress, more individual filaments were recorded and since over time more filaments 
can strike at the same location, more filaments at the higher classes were recorded. In the 
first approximation, the filaments are uniformly distributed over the entire surface 
suggesting that over time the treatment is uniform on the macroscopic scale. 
 
 
Figure 92: Discharge images (top) and filament pattern (bottom) of 12-well electrode at frequency of 250 Hz 
and electrode distance of 2mm. The shutter time is indicated on the figure. 
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Figure 93: Discharge images of 12-well electrode at 50, 250, 500 and 1000 Hz. Shutter time were 10s, 2s, 1s 
and 0.5s respectively to correspond to 500pulses. 
 
To investigate the frequency effect on filament distribution, discharge frequency 
varied between 50 and 1000 Hz. The shutter time was changed to capture 500 pulsed 
according to the discharge frequency. Figure 93 shows comparison of treatment with 
different frequencies at 500 pulses for 12-well electrode. The treatment looks uniform at 
frequencies bellow 500 Hz. The filament pattern becomes more obvious at 1000 Hz. 
Similar experiments were repeated with 6-well and 24-well electrode and the results 
displayed in Figure 94. The figure shows that at frequency of 50 Hz, all electrodes 
demonstrate microscopically uniform discharge. The smallest area electrode, 24-well 
exhibits filamentary pattern for frequencies above 500 Hz. The middle area electrode 
shows filamentary pattern at 1000 Hz. The largest area electrode shows filament pattern 
formation at 250 Hz, and this behavior becomes more sever at 1000 Hz. 
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Figure 94: Discharge images of 6-well (top), 12-well (middle) and 24-well (bottom) electrodes at 50, 250, 
500 and 1000 Hz. Shutter time were 10s, 2s, 1s and 0.5s respectively to correspond to 500pulses. 
 
In order to analyze filament pattern shorter exposure times was used. Short 
exposure time allows classification to filament classes based on size to be more precise as 
the background accumulation is not significant. Figure 95 displays images and filament 
patter at 50 pulses of frequencies of 50, 250, 500 and 1000 Hz for the 12-well electrode at 
2mm distance. As can be seen from pattern, at 1000 Hz the filaments start grouping 
together rather than randomly appearing in consecutive pulses. Similar phenomenon is 
observed at higher frequencies (2 and 3 kHz)  and is with agreement with [49]. Looking at 
the color class images shows that 50 Hz pattern shows less amount of filaments and there 
are less filaments that belong to class #4 (pink) and none belongs to class # 5 (green). As 
the frequency increases, more pink and green filament classes are observed and the amount 
of filaments and the area they occupy compared to the electrode area increase until 
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frequency reaches 1 kHz. At this frequency, the area occupied by filaments is reduced 
compared to lower frequencies, filament pattern emerges and the filaments more filaments 
appear in the higher class (pink and green). Potential explanation for the filament grouping 
could be the memory effect [49], however most of the studies indicate memory effect at 
frequencies above 10 kHz [49]. 
 
 
Figure 95: Discharge images (top) of 12-well electrode at 50, 250, 500 and 1000 Hz. Filament pattern of the 
corresponding images (bottom). Shutter time was 1s, 0.2s, 0.1s and 0.05s respectively to correspond to 50 
pulses. 
 
Figure 96 compares the total number of filaments and the relative area they occupy 
compared to the total electrode area as a function of number of pulses. Total number of 
filaments grows as the number of pulses increase (Figure 96 A and B). At 50 pulses, the 
growth of the number of filaments slows down compared to 25 pulses and the total amount 
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of filaments in 50 pulses is only 905.6, while if all the filaments were to occur in different 
location, one would expect the total # of filaments to reach 1237 pulse (the measured 
amount is 73% of the calculated amount). This number is simply the multiplication of total 
number of filaments in a single pulse (24.75) times number of pulses (50). For the lower 
amount of pulses, the estimated filament number and the measured filament number are 
not significantly different from each other; i.e. measured number of filaments for 5 pulses 
is 117 while the estimated number is 123.75 (94%). The mean area occupied by the 
filaments compare to electrode area is increasing as the number of pulses increases (Figure 
96C). However, at 50 pulses the mean area growth remains similar to the 25 pulses, 
indicating that more filaments begin accumulating in proximity to one another. Looking 
closely at the classification images in Figure 96A, one can observed that while the number 
of filaments increases, the filaments are not uniformly distributed but that the electrode has 
some regions without any filaments in it. Figure 96D shows the relationship between 
number of filaments in each class (see Table 7 for class information) and the number of 
pulses. The number of small filaments (up to 0.08 mm2 – class 1 and class 2) growth 
steadily when number of pulses was increased. The number of filaments in class 3 was 
increased with number of pulses up to 25 pulses and then was decreased at 50 pulses. The 
filaments in the largest classes (class 4 and class 5) were formed only beginning at 25 
pulses, but then were decreased at 50 pulses. Similarly, Figure 96E shows the relationship 
between mean filament area in each class and the number of pulses.Similar analysis was 
performed at a frequency of 1000 Hz (Figure 97). At frequency of 1000 Hz, steady growth 
was observed in the number of filaments as a function of number of pulses (Figure 97A 
and B). The normalized mean filament area also grew with increased number of pulses 
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(Figure 97C). The number of filaments in class 1 was the highest among other class for 10-
50 pulses (Figure 97D) immediately following by number of filaments in class 5. The 
number of filaments in all classes showed growth as a function of increasing number of 
filaments.  
 
 
Figure 96: A) Classification images based on filament size for 6-well electrode at 2mm and 50 Hz. Shutter 
exposure time was adjusted to capture 1, 5, 10, 25 and 50 pulses. B) Total number of filaments as a function 
of exposure time quantified from images in A. C) The mean percent of area occupied by filaments in the 6-
well electrode, quantified from images in A. D) Number of filaments in each class as a function of the number 
of pulses. The class colors correspond to the colors in Table 7. E) The average filament area in each class as 
a function of the number of pulses. The class colors correspond to the colors in Table 7. Five images were 
used for the analysis, error bars displays the standard deviation. 
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Figure 97: A) Classification images based on filament size for 6-well electrode at 2mm and 1000 Hz. Shutter 
exposure time was adjusted to capture 1, 5, 10, 25 and 50 pulses. B) Total number of filaments as a function 
of exposure time quantified from images in A. C) The mean percent of area occupied by filaments in the 6-
well electrode, quantified from images in A. D) Number of filaments in each class as a function of the number 
of pulses. The class colors correspond to the colors in Table 7. E) The average filament area in each class as 
a function of the number of pulses. The class colors correspond to the colors in Table 7. Five images were 
used for the analysis, error bars displays the standard deviation. 
 
Figure 97E shows the relationship between mean filament area in each class and 
the number of pulses. The largest filament area starting at 5 pulses was measured for 
filament in the largest class – class 5. The other classes showed similar mean filament area 
slightly increased with number of pulses. 
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The total number of filaments for 1 kHz was significantly lower that total number 
of filaments for the 50 Hz frequency (Figure 98B) independent of number of pulses. At 1 
pulse the mean total number of filaments was 24.75 for 50 Hz and 20.3 for 1 kHz. At 5 
pulses the numbers were 116.6 for 50 Hz and 47.5 for 1 kHz. By 50 pulses, there were 
905.6 filaments for 50 Hz vs. 263.6 at 1 kHz. The area occupied by the filaments at the 
frequency of 1000 Hz is larger compared to the area measured with 50 Hz up until 10 
pulses. Then the area occupied by the filaments at the frequency of 1000 Hz is smaller 
compared to the area measured with 50 Hz. Interesting to note that the relationship between 
number of filaments in a single pulse and in several pulses at 1000 Hz was never a 
multiplication relationship as seen for the 50 Hz conditions. For example, for 5 pulses the 
measure number of pulses was 47.5 while in a single pulse there were 20 pulses – so the 
estimated number was 2 times higher than the measured one. For 50 pulses, the estimated 
number of pulses was 1000 while the measured number is 264, which was approximately 
4 times lower than the estimated one. Therefore, with time, filaments tend to appear in 
proximity to one another. Comparing Figure 96D and Figure 97D reveals that for 50 Hz 
(Figure 96D) the dominant filament classes are class 1 and class 2 with highest number of 
filaments at almost any given number of pulses while the dominant class number for 1000 
Hz is class 5. This demonstrates once again that filaments in 1000 Hz appeared in proximity 
to one another rather than spaced resulting in smaller number of total filaments (recognized 
by the image analysis software) and appearing in larger class number while occupying 
large area.  
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Figure 98: A) Class images of 6-well electrode at 2mm, 50 Hz, 50 pulses. B) Comparison between 50 Hz and 
1 kHz condition for the total number of filaments as a function of exposure time quantified from images in 
A and C. (6-well, 2mm). C) Class images of 6-well electrode at 2mm, 1000 Hz, 50 pulses. D) Comparison 
between 50 Hz and 1 kHz condition for the percent area occupied by filaments in the 6-well electrode, 
quantified from images in A.  
 
To test the hypothesis that at low frequencies the filament distribution is more 
random compared with the filament distribution at higher frequency, Kolmogorov-
Smirnov (KS) two-dimensional analysis was used. The paired-sample Kolmogorov-
Smirnov test is a statistical test used to determine whether two sets of data arise from the 
same or different distributions.  The null hypothesis is that both data sets were drawn from 
the same continuous distribution. The algorithm  is taken from Peacock [319]and Matalb 
code was adapted from Dylan Muir (From kstest_2s_2d by Qiuyan Peng @ ECE/HKUST) 
Date:% 13th October, 2012. First the (x,y) location of each filament in a single pulse frame 
was extracted by image analysis. 100 frames were taken for statistical analysis. Each frame 
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(x,y) location was compared with (x,y) location of the rest 99 frames. The value D 
(maximum absolute difference between two empirical cumulative probability 
distributions) was calculated from [319] and compared with KS tables for alpha=0.1 [320]. 
If D was greater than alpha, the null hypothesis was rejected.  Then number of sample pairs 
for which the null hypothesis was rejected was calculated and divided by total number of 
pairs. This was used to assess the randomness of the distribution. Figure 99 shows the result 
of KS analysis comparing 50 Hz (green) and 1000 Hz (pink) measured with 6 well 
electrode at discharge gap of 2 mm. KS analysis shows that about 25% of the filament 
patterns at 50 Hz were random, compared to 5.5% for 1 kHz. This results indicates that the 
filament patterns at higher frequencies are less random, perhaps due to a volume memory 
effect or charge deposition [[47]].  
 
 
Figure 99: A) Class images of 6-well electrode at 2mm, 50 Hz, 1 pulses. B) Comparison between 50 Hz and 
1 kHz condition of Kolmogorov-Smirnov 2D-analysis for 1-pulse frames (N=100).  
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Figure 100 compares examines the effect of electrode gap on the mean total number 
of filaments, they relative area and KS analysis at discharge frequency of 1 kHz.  It can be 
seen that 1mm discharge has higher number of total filaments for all number of pulses 
(Figure 100A, B). The highest number of filaments was recorded for 50 pulses and then 
there was a decrease in the total number of filaments. Relative filament area was higher for 
1mm discharge compare to 2mm discharge and the biggest difference was observed for 25 
and 50 pulses (Figure 100C). KS analysis showed that 1mm and 2mm are not random. 
Only 3% of the filament frames were random at 1mm compared to 5.5%, which was not 
statistically significant.   
 
 
Figure 100: A) Class images of 6-well electrode at 2mm, 50 Hz, 1 pulses. B) Comparison between 50 Hz and 
1 kHz condition of Kolmogorov-Smirnov 2D-analysis for 1-pulse frames (N=100).  
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Figure 101: A) Class images of 6-well electrode at 2mm, 50 Hz, 1 pulses. B) Comparison between 50 Hz and 
1 kHz condition of Kolmogorov-Smirnov 2D-analysis for 1-pulse frames (N=100). 
 
Figure 101 compares the effect of electrode area on total number of filaments and 
their relative area. Discharge images show uniform distribution on the macroscopic scale 
at 50 Hz for all three electrodes (Figure 101A). High frequency of 1 kHz show discharge 
patterns even on the macroscopic scale. Figure 101B shows the normalized total number 
of filaments per unit area. Both 12 and 24 well electrodes had higher number of filaments 
per unit area compared to 6-well electrode at 1 kHz. At 50 Hz 12 well electrode had the 
highest number of filaments and 24 and 6-well electrodes had similar number of filaments. 
The percent area filled with filaments was the highest for 6well electrode at 50 Hz compare 
with 12 and 24 well electrodes, which has similar amount of filaments. At 1 kHz filament 
area grew reversely proportional to electrode size: smallest area electrode had the largest 
amount of area filled with filaments and largest area electrode had the smallest amount of 
area filled. 
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9.4. Discussion  
This chapter explored the filament pattern formation as a function of NT-plasma 
parameters such as inter-electrode gap, discharge frequency and treatment time and 
electrode area in terms of filament number and their area. It was found that the number of 
filaments and their area growth with treatment time for both low and high frequencies. The 
number of filaments and their area increase with frequency up to 500 Hz. However, for 
frequencies 1 kHz and more the number of filaments decreased compared to frequencies 
bellow 500 Hz. This effect can be explains in terms of volumetric memory effect [321]. At 
higher frequencies, each streamer has a path, which is “marked” by diffused decay of the 
previous streamers. At 1000 Hz pre-ionization of the gas from previous pulses causes 
filaments to organize in structure, causing the treatment to be non-uniform. This effects 
begins at lower frequencies with smaller area electrodes compared with larger are 
electrode. Spherical electrode exhibits strong streamer channels at all the measured 
frequencies. This explanation also fits the results of the Kolmogorov Smirnov analysis, 
according to which higher frequency discharge has less random filament distribution. In 
addition, it was found that smaller inter-electrode gap has higher number of filaments 
compared with larger gap and the filaments area is larger in the smaller electrode gap.  
Electrode area was found to impact number of filaments per unit area and their normalized 
area especially at higher frequencies. At frequency of 50 Hz, percent area filled with 
filament decreased when electrode area decreased. On the other hand, at frequency of 1 
kHz, percent area filled with filament increased when electrode area decreased.  
Those differences in filament distribution in space and time correlate with the 
epithelial damage found as the results of NT-plasma treatment (Chapter 8:. Less random 
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filament pattern that was recorded at high frequencies caused severe damage to the 
epithelium layer. Smaller electrode area were also correlated with more damage to the limb 
tissue. The funding of this study guides the design of NT-plasma parameters for 
optimization of NT-plasma treatment to enhance biological functions one hand and reduce 
the tissue damage that can be associated with higher NT-plasma dose and more fixed 
filament pattern. 
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 Discussion and Summary 
 
The focus of this thesis was to better understand the potential of NT-plasma as a tool 
in the promotion of skeletal cell differentiation and development. In this work, the mechanisms 
of NT-plasma action on cells and tissues were evaluated using a threefold approach, to 
determine 1) the direct physical effects, 2) chemistry and ionic interactions, and 3) the 
biological effect on the cells and tissues. The culmination of this work reports the conditions 
in which NT-plasma can enhance cell differentiation and tissue development, and the cell and 
tissue response to variations in NT-plasma dose, environmental conditions (based on culture 
media), electrode size and time of NT-plasma treatment. Furthermore, this study demonstrated 
for the first time the NT-plasma promoted redox dependent changes to enhance intracellular 
ROS associated signaling and promote limb autopod developmental.  
Of particular interest, was the finding that NT-plasma treatment promoted survival, 
growth and enhanced differentiation of cartilaginous elements within the embryonic mouse 
autopod. The effect of NT-plasma treatment was determined by visual comparison of non-
contralateral limbs using a novel grading system developed to assess developmental status. 
Additionally, the autopod experiments demonstrated a single well-timed treatment with 
NT-plasma had the ability to augment a highly complex network of cellular interactions 
contributing to accelerated limb development. These findings highlighted the potential of 
NT-plasma to initiate specific cellular signaling cascades within developing tissue. 
Together these findings solidly confirmed NT-plasma technology has the potential to be 
utilized as a tool to enhance bone fusion and improve healing after skeletal injury and thus 
progress the field of plasma medicine.  
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Additional aspects addressed this thesis, are an understanding of mechanisms by 
which NT-plasma treatment affects cellular behavior through the generation of intracellular 
ROS and extra- and intracellular calcium flux. These findings were conclusively 
determined by the  promotion of murine limb autopod development and mesenchymal cell 
differentiation. This study directly identifies calcium as a prerequisite for NT-plasma 
induced limb elongation. It was determined that limb elongation, but not survival, requires 
both NT-plasma treatment and calcium. Furthermore, both cellular differentiation and the 
enhancement of limb autopod elongation by NT-plasma were dependent on increases in 
intracellular calcium, through the activation of voltage gated calcium channels on the 
plasma membrane. A second possible reason NT-plasma enhanced autopod growth was its 
inhibition of epithelial overgrowth. In limb regeneration a thickening of the epidermis has 
been shown to inhibit signaling to the blastema halting the regeneration process [305-307]. 
The observed decrease in epithelial thickening and increased limb growth after NT-plasma 
treatment supports this mechanism. Furthermore, when the skin of the autopod was 
removed, the limb showed increased elongation and development confirming those 
findings. One explanation for our findings is the presence and distribution of H2O2 positive 
cells throughout the culture period which indicates the NT-plasma treatment has altered 
signaling and development. NT-plasma also affects the cartridge directly as indicated by 
the promotion of growth and elongation of the skinless autopod. 
It was established that NT-plasma can be fine-tuned to promote the desired biological 
responses. Cellular response and treatment effectiveness were tested for variety of plasma 
parameters. Effective NT-plasma dose was governed by both the biological model to which 
it was applied and to electrode geometry and size. Specifically, energy density was not an 
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effective method for predicting cellular response nor to determine the resulting filament 
pattern created by the electrode. In order to minimize tissue damage, NT-plasma dose can 
be optimized by changing discharge frequency or treatment time. 
In conclusion, this thesis identifies the potential of plasma medicine technology to 
induce and recapitulate normal cellular signaling and its potential in regenerative medical 
applications for skeletal tissue engineering, and if directly applied to improve healing after 
skeletal injury.
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